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1. INTRODUCTION 
 
“ The scientist does not study nature because it is useful; he studies it 
because he delights in it, and he delights in it because it is beautiful. If 
nature were not beautiful, it would not be worth knowing, and if nature were 
not worth knowing, life would not be worth living ”. 
- Julies-henri Poincare (1854-1912). 
 
This simple thought could apply to the field of science where most of 
the mysterious matters in this universe are still unravelled and unknown. 
Understanding the  basic structural and functional organisation of  any 
organism is still difficult, thus giving a quest for scientific researchers.  The  
eternal human need for hope of relief, for sympathy, and that something should 
be done, which is felt by those who are suffering  is the most of the aspects of 
medicine that works in a relative and suspicious fashion as there is no definite 
cause that can be framed for a disease.  No disease suffered by a live man can 
be known, for every living person has his own peculiarities and always has his 
own peculiar, personal, novel, complicated disease, unknown to medicine , one 
such mysterious disease that  dates back to the very origins of mankind is , a 
throbbing pain that is mostle one sided and comes with auras or flashes of light 
is migraine.   
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1.1. MIGRAINE 
Migraine is one of the most interesting illnesses to study, known since 
the dawn of time, having accompanied mankind throughout its history. The 
majority of great medical thinkers have expressed opinions about it, something 
which does not happen with other illnesses. 
1Headache was accredited as a supernatural possession by an evil spirit 
during the archean era and for the Greeks. To exorcise the diabolic spirit , 
‘trepanation’ a method of drilling  holes in the brain was one of the home 
remedies used at that time. 
1Hippocrates recommended blood letting as a treatment and the Romans 
used opium in beverages as an analgesic . The concepts on the supernatural 
origins of illnesses resurfaced during the middle ages.  
1 From the 9th to the 13th century, when the Arab culture of Andalusia 
emerged, medicine steered towards the path of natural science and durng this 
period some of the causes of migraine were established. 
1 
‘Hemikrania’, the etymological root of the word migraine is a greek 
word meaning ‘hemi’- half and ‘kranion’-skull, “pain on the one side of the 
head”18 
Although once in lifetime everyone would have experienced the 
discomfort that headache or cephalea can cause, only 16% of the population 
suffers from the intense pain generated by migraine. 
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Migraine is defined by the international headache society (IHS) as an 
intermittent, recurrent unilateral disabling headache associated with nausea 
sensitivity to sounds and light2.A useful description of migraine is a benign 
and recurring syndrome of headache associated with other symptoms of 
neurologic dysfunction in varying admixtures. As  the second most common 
cause of headache often accompanied by nausea and vomiting it afflicts 
approximately 15% of women and 6% of men.  
3As per the world health organisation , 28 million people suffer from 
migraines. Migraines occur about three times more frequently in women than 
in men. 25% of all women with migraine suffer four or more attacks per 
month; 35% of migraineurs experience one to four severe attacks per month 
and 40% of migraineurs experience one or less than one severe attack a month.  
Each episode of headache lasts from four hours to three days. Occasionally, it 
lasts longer. Migraine most commonly strikes women of child bearing age 
between ages 20 and 40 with a slightly higher age range for men. Due to its 
inconsistent nature approximately 50% of the migraineurs go undiagnosed or 
mismanaged to this day.  
1.2. MIGRAINE AND VESTIBULAR DYSFUNCTION: 
Patients with migraine frequently have vestibular complaints ranging 
from vertigo to less specific symptoms of dizziness, unsteadiness and head 
motion intolerance4.  Approximately 16% of the adult population are affected 
by migraine at some time in their lives5 and the lifetime prevalence of 
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‘dizziness’ (comprising both vertigo and non-vestibular dizziness) has been 
found to be 23% in a large population-based survey6 . Thus, among the general 
population , about 3–4% would be expected to have both migraine and 
‘dizziness’ by pure coincidence. However, the association of vestibular 
dysfunction as the mechanism for dizziness in migraineurs have been shown in 
experimental animal studies.  
Moreover in medical literature, the role of vestibular system is to sense 
the head and body movements and the attitude of the body relative to gravity 
in order to generate proper motor responses to head , neck and trunk muscle to 
maintain optimum vision with steady balance7. Although patients cannot 
clearly describe vertigo which presents as a vague symptom , a structured 
interview during clinical examination is necessary. It can be defined as a 
transient spinning sensation or a sense of swaying and tilting, exacerbated by 
movement of the head. Vertigo is intermittent , occurs as a single or recurrent 
episodes and lasts for seconds, minutes, hours or days and it often 
accompanies nausea and vomiting.  
In individual migraineurs the critical question is whether vertigo is 
related to migraine or not. Migrainous vertigo (MV) actually concur much 
more often in migraineurs and was recognized as one of the most common 
cause of episodic vertigo among neurologists and migraine specialists11 
Although the classification of IHS8 has not included migrainous vertigo,  
till date its specific criteria have been proposed and utilized in many clinical 
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trials9.10. Still a residual grey area remains unknown to substantiate that mild 
vestibular dysfunction may presents with vertigo. 
 
1.3.VESTIBULAR EVOKED MYOGENIC POTENTIAL: 
Diagnostic testing of the vestibular system is an essential component of 
treating patients with balance dysfunction. The clinical application of 
vestibular spinal cord reflex registration started with the work developed by 
halmagyi and Colebatch in 199212  which laid the foundation for its use as a 
diagnostic tool in patients with vestibular disorders. Until recently, testing 
methods were constrained to evaluate the integrity of the horizontal 
semicircular canal, which is only a portion of the vestibular system. Recent 
advances in otolaryngology have afforded clinicians the ability to assess 
otolith function through Vestibular Evoked Myogenic Potential (VEMP) 
testing. The American academy of neurology proposed a new neuro-otologic 
method to provide information about the saccule and the inferior vestibular 
nerve on each side separately11 through VEMP.   
VEMP is a short latency evoked potential is one of the many sound 
evoked muscle reflexes or “sonomotor responses” that are believed to be 
generated from acoustic stimulation of the saccule with loud sound13.  It is a 
series of electric waves that are generated by the vestibular pathway when the 
loud sound transmits through the middle ear , the saccule, the inferior 
vestibular nerve, the vestibulospinal tract projecting to accessory nucleus and 
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finally terminating in the cervical muscles14.  Evoked by acoustic, bone or 
galvanic stimulation, the VEMP is a biphasic potential that represents the 
response of the otolith organs to loud stimulation. An adequate  sound is 
delivered to one ear while the muscular activity is recorded in the ipsilateral 
sternocleidomastoid muscle (SCM). It has been shown that the initial peak of 
the VEMP response represents the compound action potential (CAP) of the 
vestibular nerve fibres synchronously activated during the acoustic stimulation 
with loud sound15. 
In the last decade there have been remarkable strides in unravelling the 
mystery of the clinical utility of VEMPs as a diagnostic procedure in migraine. 
Presently there is lack of evidence from well-contolled prospective clinical 
trials on VEMP testing regarding the management and improvement of clinical 
outcomes. Standardization of VEMP and methodological issues differs in 
various studies in literature still remains to be clarified. 
When the normal pathological cut-off point is unknown in a consistent 
manner or when the variables that influence the outcome are numerous and 
their direction is also unknown, it is necessary to standardize the procedure to 
interpret the results. Our work was designed to standardize the VEMP 
response among different age groups . We also intended to study how far the 
different modes of neck torsion and the placement of reference electrodes at 
different bony prominences affecting the VEMP parameters. It was also 
designed to compare the VEMP findings in controls with migrainous patients 
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with and without vertigo, and lastly to test the sensitivity of VEMP in 
diagnosing MV. This relatively new  procedure may supplement conventional 
testing in  different populations and possibly steer towards previously 
inaccessible information about the vestibular system. 
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2. REVIEW OF LITERATURE 
 
2.1.HISTORY OF MIGRAINE:1,16 
Migraine one of the oldest known medical disorder was recorded as 
early as 3000B.C. Ancient Egyptians had made note of it sometime during 
1200B.C. Hippocrates in 400B.C had described the visual aura that can 
precede the migraine headache and the relief offered by vomiting. Aretaeus of 
Cappadocia was credited as the discoverer of  migraines in the second century  
The word ‘Migraine’ was derived from the term hemikrania used by 
Galenus of Pergamon. Abulcasis applied a hot iron to the head or insertion of 
garlic into an incision made in the temple to relieve migraine. 
Hot irons, bloodletting and even witchcraft were part of the treatment in 
the middle ages. Abu Bakr Mohamed related this headache with different 
events in the lives of women especially during menopause, following delivery 
and abortion. 
"Megrim" recognized as classic migraine was one of the five major 
types of headache described in 'Bibliotheca Anatomica, Medic, Chirurgica', in 
1712.  Ergotamine tart to relieve migraine was advocated by Graham and 
Wolff in 1938. Vascular theory was proposed by Harold Wolff in 1950, later 
the neurogenic came into being. 
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2.2. MIGRAINE HEADACHE: 
Migraine is a common neurological disorder, which affects up to 6% of 
men and 18% of  women in the general population 19,20. Anyone  can have an 
occasional migraine attack, if the triggering factors are strong enough, but 
migraine attacks must be recurrent before one is defined as a migraine patient. 
Common types of migraine include migraine with typical aura (MA) and 
migraine without aura (MO) according to International Headache Society 
criteria (IHS) 21(International Headache, 1988,Headache Classification 
Subcommittee of the International Headache, 2004).  
2.3. CLASSIFICATION OF MIGRAINE: 
2.3.1.International Headache Society Classification of Migraine 
• 1.1 Migraine without aura 
• 1.2 Migraine with aura 
o 1.2.1 Migraine with typical aura 
o 1.2.2 Migraine with prolonged aura 
o 1.2.3 Familial hemiplegic migraine 
o 1.2.4 Basilar migraine 
o 1.2.5 Migraine aura without headache 
o 1.2.6 Migraine with acute onset aura 
• 1.3 Opthalmoplegic migraine 
• 1.4 Retinal migraine 
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• 1.5 Childhood periodic syndromes that may be precursors to or 
associated with migraine 
o 1.5.1 Benign paroxysmal vertigo of childhood 
o 1.5.2 Alternating hemiplegia of childhood 
• 1.6 Complications of migraine 
o 1.6.1 Status migrainous 
o 1.6.2 Migrainous infarction 
• 1.7 Migrainous disorder not fulfilling above criteria 
 
2.4. CLINICAL CHARACTERISTICS OF MIGRAINE: 
2.4.1. Migraine with and without aura: 
Unilateral throbbing headache, accompanied by nausea or vomiting, 
photophobia and phonophobia are characteristics of migraine attacks. Physical 
exertion typically worsens the symptoms. 17About 20% of migraineurs have 
aura symptoms (MA) preceding a headache which usually starts within an 
hour after the aura has occurred. 18In MA, a visual aura with fortification 
spectrum is the most common aura type, with hemisensoric symptoms next in 
frequency. Speech disturbances and unilateral weakness are less frequent. 
Migraine attacks usually last from 4 to 72 hours.  Vertigo and dizziness are the 
common symptoms among migraineurs aura22. Recently, migrainous vertigo 
was evaluated to be the most common cause of spontaneous recurrent vertigo 
23
, but is not presently included in the IHS criteria.  
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To identify Migrainous vertigo (MV) atleast two vertigo attacks24 with 
one of the following migrainous symptoms such as headache, photophobia, 
phonophobia, visual or other auras. Mostly MV mimicks benign paroxysmal 
positional vertigo (BPPV). Unlike BPPV, migrainous vertigo starts early in life 
have shorter-lasting episodes with frequent recurrences associated with 
atypical positional nystagmus, and migrainous symptoms25. 
27Pathophysiological link exists between migrainous vertigo and 
symptoms of Meniere’s disease. Symptoms of migraine like headache, 
photophobia aura are also experienced in 45% of the patients with menieres 
disease26.  
 
2.5. GENETICS AND PATHOPHYSIOLOGY OF MIGRAINE: 
Genetics and environmetal factors 28,29 play a part in the etiology of 
migraine. First-degree relatives of probands with migrainous aura (MA) have a 
relative risk of developing MA, whereas their spouses have no risk. The 
relative risk of MO for first-degree relatives is much lower. Gene identification 
for the common types of migraine has come and with conflicting results. 
Migraine genetics are associated with studies related to dopaminergic 
system 30-33, the serotonergic system 34-36, mitochondria 37, the endothelial 
system 38, and homocysteine-related genes 39. 
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  Results of linkage studies in common types of migraine. 
 
2.5.1.PATHOGENESIS OF MIGRAINE: 
Although not much is known about why and how the attack actually 
begins40-42more literature are available about the pathogenesis during the 
attack.  . According to the current view headache is preceded by suppression of 
brain activation  and  a depolarization wave that propagates across the  
occipital cortex at rate of 2 to 3-mm/min, this so called migraine is caused by 
“cortical spreading depression” (CSD) 43is followed by a failure of brain-ion 
homeostasis, efflux of excitatory amino acids like K+ from nerve cells, 
enhanced energy metabolism44, and transient increases in cortical blood flow 
followed by sustained flow decreases45. Activation of the trigeminovascular 
system is implicated as the prime pathophysiology of migraine.(Figure 1).  
48Trigeminal nucleus caudalis via its fibers causes perivascular release 
of vasoactive neuropeptides which leads to vasodilatation, neurogenic 
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inflammation causing central transmission of pain impulses leading to 
headache. A possible link between CSD and trigeminovascular activation in 
migraine with aura is studied by Bolay et al. In animal models, increased 
cortical concentration of cyclic guanosine monophosphate (cGMP) and 
increased extracellular K+ 46 potentiated CSD which inturn induced excess 
release of nitric oxide (NO) a potent endogenous vasodilatator thus providing 
an evidence for probable mechanism for recurrence of migraine47. 
Infarction of  posterior cerebral  territory is commonle seen in migraine 
mostly affecting the cerebellum54,55. Stroke caused by migraine is more 
common in women49 and migraine was considered to be an independent risk 
factor for stroke in women of childbearing age 50-52 especially those with MA 
53
.  
56
 It has been found that Iron homeostasis is progressively impaired in 
the periaqueductal gray matter of patients with migraine with and without aura. 
As the periaqueductal gray matter is at the center of the descending 
antinociceptive neuronal network it is believed to present a possible role in 
migraine attack generation, potentially by the dysfunction of the 
trigeminovascular nociceptive system 57. 
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Figure 1. pathogenesis of migraine :  
 
TGG = trigeminal ganglion; SPG = sphenopalatine ganglion;  
SSN = superior sagittal sinus 
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2.5.2. ROLE OF NEUROMODULATORS: 
A.) Serotonin / 5-Hydroxytryptamine: 
58Reduced systemic 5-HT levels during interictal period and raised 
levels are seen during migraine attacks. In an animal model serotonin  affected 
the synaptic transmission in the axon terminals of peripheral trigeminovascular 
neurons and in the cell bodies of central trigeminovascular neurons 58. The 
serotoninergic fibres have projections to vestibular nuclei portraying the 
probable mechanism of vertigo associated with migraine. 
B.) Calcium Gated Channels 59: 
. In rats, P/Q-, N-, and L-type voltage-gated calcium channels showed 
involvement in neurogenic trigeminovascular dural vasodilatation, which may 
imply involvement in trigeminovascular nociception60. P type neuronal 
calcium channels mediate serotonin release which may cause migraine attack. 
 
C.) Glyceryl Trinitrate: 
The initial headache is thought to originate from direct action of the 
NO-cGMP pathway , while the delayed migraine is likely to result from 
trigeminovascular activation 62. Scientific evidence suggests that NO plays an 
important role in primary headaches 61,63. It has multiple physiological actions 
such as endothelium-dependent vasodilatation and neurogenic vasodilatation 
both of which may be mediated via perivascular nerves 64, and may release 
relevant neurotransmitters such as calcitonin gene-related peptide (CGRP) 
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from trigeminal fibers 65-66. Moreover, NO as a neurotransmitter in the central 
nervous system (CNS), is of importance in pain perception 67. 
 
D.) Endothelin 1: 
In migraine patients, increased plasma levels of endothelin 1, a potent 
vasoconstictive peptide, has been reported during ictally 68-70 and interictally. 
Endothelin 1 stimulation mediate an inhibitory action on NO synthesis by type 
A receptors in vascular smooth muscle cells 72. 
 
2.6. THE PERIPHERAL AND CENTRAL VESTIBULAR SYSTEM: 
71The cochlea and the vestibular apparatus are homed in the petrous part 
of the temporal bone. The organ of corti along with the semicircular canals and 
otolith organ are integrated in the brain stem and in the cerebellum by means 
of commissural, inferior olivary, and reverberating circuits. 
 
2.6.1. The Peripheral System74-75: 
The peripheral vestibular system comprises of the vestibular labyrinth 
with two otolith organs (the saccule and utricule) and a set of three 
semicircular canals. These form a coordinate system with the anterior and 
posterior canal in vertical positions almost orthogonal to each other, while the 
horizontal canal makes a 30° angle with the horizontal plane. 
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The endolymph movement within the canals stimulates these hair cells 
and thus transmits a biologic signal to an afferent neuron. The saccular and 
utricular macules sense linear acceleration, while the cristae of the three 
semicircular canals sense angular acceleration of the head.  
 
2.6.2. The central vestibular system76-77: 
The central vestibular system consists of vestibular nuclei in the brain 
stem, cerebellar-vestibular interaction, vestibulospinal pathways, visual-
vestibular interaction, and neck-vestibular interaction. The four vestibular 
nuclei namely superior, lateral, medial, and inferior are stimulated by afferent 
fibers from proprioceptive systems and efferent fibres especially from the 
cerebellum interact with signals from the vestibular organs.  
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The Central Vestibular System. 
 
Alternate pathways also exist, with chains of interneurons forming 
reverberating circuits. These interact and fine-tune more specific end-organ 
reflexes.  
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2.7. LABORATORY EXAMINATIONS OF THE VESTIBULAR 
SYSTEM: (is given below). 
Eye movement recording  - Electronystagmography /  
   electro-oculography. ENG/ EOG 
- Videonystagmography / video-  
   oculography 
VNG/ VOG 
- Selera search coil 
Horizontal semicircular canal - ocular motor screening  
- Positional testing 
- Earth- vertical axis rotational testing.  
  EVAR 
- Head only rotational testing. HORT 
Vertical semicircular canal  - head impulse test 
- Selera search coil 
Utricle  - unilateral centrifugation 
- off-vertical axis rotation OVAR 
Saccule - VEMP 
Vestibular tests with uncertain focus - Subjective visual vertical / subjective 
visual horizontal. SVV/SVH 
- Galvanic vestibular stimulation. GVS 
 
According to Zhou149 a new possible diagnostic method that are specific 
for vestibule-spinal pathways and can detect saccular lesions is  vestibular 
evoked myogenic potential.  
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2.8.VESTIBULAR EVOKED MYOGENIC POTENTIAL: 
Vestibular Evoked Myogenic Potential (VEMP) is a short latency 
biphasic muscle potential that represents the response of the otolith organs  
when the vestibular system is presented with loud sound. It can also be evoked 
by acoustic, bone or galvanic stimulation. To produce a reliable VEMP the 
primary recording site used clinically is the sternocleidomastoid (SCM) along 
the cervical spine. Recent evolving field in research is VEMP testing as this 
new procedure may supplement conventional testing in difficult-to-test 
populations or possibly may be able to evaluate previously inaccessible 
information about the vestibular system. However one must analyze previous 
research to fully understand the field, before developing  a new clinical test of 
the vestibular system,  
 
2.8.1. HISTORICAL RESEARCH IN VEMP:- 
The sensitivity of the vestibular system to sound was first identified by 
Pietro Tullio in 1929. Loud sounds when given produced head movements due 
to vestibular origin that was proposed by von Bekesy 78 in 1935. VEMP 
evoked by clicks was first recorded from the scalp by 73Dawson  in 1954 
followed by Geisler and Rosenblith recorded the same from the occiput in 
1962 74-75. Shortest latency responses were recorded from  the cervical muscles 
following loud AC tone bursts over the scalp by 76Bickford in 1963. They were 
the first to observe that these responses were basically of myogenic in origin 
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and the amplitude of the response was equally related to the tension in the 
muscles. 77A short latency that peaks initially at 13 ms is called as the ‘inion 
response’ that are produced by clicks of 120dB and they were foud to be 
affected by the level of tonic neck extension which then was contradicted by 79 
Cody et al. who called it as a ‘vertex response’ and argued that it was mediated 
by the cochlea. Although myogenic both the responses differed with frequency 
and threshold of occurrence80,83.   
 
81-82 The inion response was absent when ‘Tack’ a procedure which has 
the tendency to damage the saccule was done by Townsend. As the potential 
evoked by the background of EMG activity was smaller, it has to be 
averaged84 .  
85-86Colebatch distinguished the short latency response as vestibular-
dependent component that arise from the ipsilateral SCM muscle and cochlear-
dependent component (crossed response) that arise from the contralateral SCM 
muscle when loud clicks were given unilaterally. He proposed that the 
stimulus spread to the utricule that has bilateral projections to the 
sternocleidomastoid muscle thus producing the crossed response.  
Similar bilateral response was also obtained from the tonically active 
masseter muscles 87as well as trapezius 88and splenius capitis 89. Depending 
upon the tension developed and the postural control the responses can also be 
recorded from the triceps and soleus muscles 90-92.  
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2.8.2. cVEMPs recorded from clicks and tones delivered via headphones :  
It is a technique based on testing the residual acoustic sensitivity of the 
sacculus,  
 
 
Click evoked VEMP 
2.8.2.1. Electrogenesis: 
An EMG recording of the inhibition of the maximum contracting SCM 
muscle that represents a  short period of multiple motor unit firing averaged 
together produces the evoked myogenic potential.  When the nerve endings of 
the saccule and utricle are stimulated , the impulses generate inhibitory post 
synaptic potential in the ipsilateral sternocleidomastoid and the utricle 
generates excitatory postsynaptic potentials in the contralateral 
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sternocleidomastoid 116. The  time required to inhibit a short period of motor 
unit firing ranges from 2 to 8ms118   
 
A) Effect Of Firing Rate: 
         117
 A short period of reduced firing probability evoked an inverted 
motor unit potential (MUP) using unrectified averaging. 
  
117When the firing rate was set to be 20ms of muscle contraction (MUP) 
and a stimulus rate of 5kHz , an amplitude of 20µV (µV peak to peak) was 
obtained and it directly correlates with the sound intensity and the threshold. 
When the threshold and intensities are reduced an inverted MUP was obtained 
explaining that they influence the properties of VEMP. 
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B) Effect Of Duration Of Inhibition: 
With longer durations of the stimulus, there is more duration of inhibition 
of motor unit and thus  prolong the p13 and n23 latencies. The same effect if 
clinically applied states the reason for  the prolonged latencies seen in superior 
canal dehiscence 119. 
2.8.3. Sound stimulus:  
A sound intensity of 120 to 140 dB produce eddy current formation in 
the endolymph of the saccule thereby displaces the hair cells and activates the 
vestibular afferents120. A caliberted source and an intact middle ear to conduct 
the sound to the end organ is essential for eliciting VEMP successfully. The 
minimum required stimulus to evoke VEMP was an intense loud clicks or 
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short tone bursts (STB)  of  about 95-100 dB above normal hearing level 
(nHL) that are  equivalent to 140-145dB sound pressure level (SPL) and they 
are considered as the safe limit85. For people with above 60 years of age the 
suggested limit of 95 db nHL and 0.1-millisecond duration are adequate. 
Hence clicks or short tone bursts are not advisable for patients with tinnitus85. 
With even as small as 10.75dB air-bone gaps VEMP response was not 
recorded138. Threshold levels of the stimulus should be increased as age 
advances96. 
Clicks are given continuously to each ear at 200 msec intervals 
(5/second). 122-128 Usually STB and clicks were used to measure VEMP 
response, though their response rate has not yet been proved clinically. 
 
2.8.4. Amplifier setting129 : 
  To evoke a VEMP response without any decrement in the amplitude,  
the potentials are recorded by averaging 250 presentations  with stimulus rates 
up to 5 Hz/sec, amplified 5000 times and band pass filtered from 30 to 3000 
Hz. The optimum frequency was considered between 500 and 1000 Hz. A 
minimum of two averaged responses are recorded to ensure the reproducibility 
of VEMP.    
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2.8.5.BASIC HEAD POSITIONING AND ELECTRODE LAYOUT : 
2.8.5.1.PLACEMENT OF ELECTRODES: 
    
 As the amplitude of the response depends on the tonic contraction of 
the muscle, 128anterior SCM muscle at its middle third was chosen for the 
active electrode location as it is easily accessibly for recording. Forehead was 
chosen for the ground electrode and with the reference electrode over the 
sternum128. 
With subject variations, delayed VEMP responses has been observed for 
people with fat and long necks as the signal comes from underneath the muscle  
and from longer distance respectively. Wrists can be used as a reference to 
avoid volume conduction120. 
 
2.8.5.2. POSITIONING OF HEAD: 
Subjects must lie supine and must activate their SCMs by lifting their 
heads forwards towards the centre after the sound stimulus was given and the  
ade- quate levels of tonic neck muscle contraction are maintained during the 
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recording which corresponding to a mean EMG of about 60µV. Activation of 
the SCM muscle can also be done by various means like  
• pushing the head forward against the resistance of a padded bar or 
an inflated sphygmomanometer while sitting upright  
• lifting head forwards against resistance while lying supine  
• turning head away from the source of stimulus while 
semirecumbent. 
  
127 for every run of acoustic stimulation subjects are asked  to tense the 
muscle during and relax between runs. To produce less torque for the patient, 
colebach recommended simply tilting the entire body up by about 30 degrees. 
Presently very few literatures give amplitude norms for this procedure. The  
magnitude of the p13-n23 amplitude of  VEMP response is largely determined 
by click intensity and the level of tonic SCM contraction139 . During recording, 
if VEMP waveforms are not obtained feedback must be given to subjects to 
control the levels of neck muscle tension.  
2.8.6. VEMP RESPONSE: 
The response evoked in the neck EMG is averaged and presented as a 
VEMP. The VEMP arises from modulation of background EMG activity and 
differs from neural potentials in that it requires tonic contraction of the muscle. 
The latency, amplitude, and threshold for the p13-n23 wave is measured. 
Though the amplitude is the most reliable measure121 and latencies are less 
reliable, latencies are used to confirm a particular waveform as VEMP.  
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 Responses were recordable even in sensorineural hearing loss 
portraying that it needs the activation of the relevant muscles130.   
  
131The ipsilateral responses are always from the saccule and are 
inhibitory whereas the contralateral crossed responses are mostly from the 
utricle and are excitatory.  Better ipsilateral and the contralateral responses 
were seen with click evoked VEMPs and DC or tap evoked VEMPs 
respectively132-137. 
2.8.6.1. WAVEFORMS OF VEMP: 
 
135The response consists of 2 biphasic peaks, p13–n23 and n34–p44 
with an initial positivity or inhibition (p13) followed by a negativity or 
excitation  (n23). Later components (n34, p44)  have a lower stimulus 
threshold and are nonvestibular  probably cochlear in origin. The short-onset 
latency of the VEMP (about 8 milliseconds) indicates that it is likely to be 
mediated by an oligosynaptic pathway, possibly disynaptic and consisting of  
primary vestibular afferents beginning in the saccule via the inferior vestibular 
nerve, lateral vestibular nucleus, medial vestibulospinal tract to the accessory 
nucleus and finally ending at the motor neurons of the SCM muscle127. 
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A.)  p13 latency100-103: 
The first negative polarity of the biphasic VEMP  waveform  is the p13 
latency that appears approximately at 13ms. It is prolonged in delayed or 
incomplete myelination and is significantly longer in newborns than in adults. 
Due to the structural differences mean p13 latency is shorter in children 
compated to that of adults. 
B.) n23 latency104 : 
The n23 latency is defined as the positive polarity of the biphasic wave  
that appears approximately at 23ms. The  immediate trough following the p13 
wave  is approximately at 23 ms (n23). Both the latencies of the waveform are 
affected by the intensity of the sound stimulus and the levels of neck torsion. 
C.)  p13-n23 amplitude : 
105The amplitude  is defined as the peak-to-peak p13-n23 in  µV of the 
VEMP response  and is largely dependent  on the  click intensity and the level 
30 | P a g e  
 
of tonic SCM contraction.95 Some authors reported absent response at rest and 
at 70 years of age. It was found to have a linear correlation with sound 
intensity above a certain threshold.127VEMP amplitude has been considered 
the reliable parameter as it varies if there is no proper neck torsion or any 
pathological change that affects the neuro-muscular pathway. 
D.) Inter-amplitude difference ratio(IAD) : 
93.94Also called as VEMP asymmetry ratio (VAR)  is defined as the ratio 
of the sum of the amplitudes of both ears. It is expressed in percentage (%). It 
signifies the side-to-side differences in reflex amplitude and is expressed as 
percentage and calculated  using the following formula 96IAD% = (AR- 
AL)/(AR+ AL) * 100, where AR and AL are amplitude of the right ear and that 
of the left ear respectively. 
E.) Other than p13 and n23 waveforms: 
The consecutive wave pattern following p13 and n23 has a trough at the 
latency near 34 ms (n34) and peaks at about 44 ms (p44) and the waves 
probably originates from cochlear afferents133. Usually, clinical interpretation 
of a VEMP test includes latency p13, n23, p13-n23 amplitude and 
interamplitude difference ratio. 
128-129The initial positive–negative response (p13n23) is vestibular 
dependent and strictly ipsilateral to the stimulus. A small contralateral 
response of opposite polarity, with an initialnegativity (n1p1, crossed neural 
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response), is present infrequently . These are small, becoming prominent only 
in the presence of vestibular hypersensitivity to sound. 
2.8.7. VEMP RECORDED FROM DIFFERENT STIMULI: 
 Other stimuli used to evoke cVEMPs are AC sound, skull-taps and BC 
vibration . cVEMPs decreases in frequency of occurrence and amplitude with 
age 97-99 inspite of the stimulus type.  
108AC tone burst produced larger responses  due to greater stimulus 
duration, transmitted sound energy and frequency tuning ompared to click 
cVEMPs,. The best frequency lies between 200 and 1000 Hz 106-109.  cVEMPs 
has been elicited by tapping the forehead with a clinical reflex hammer110. No 
variations in the response has been found between the tap evoked and 
cVEMPs.  
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89,107Using short tone bursts STB VEMPs were recorded from the 
splenius capitis during tonic contraction of the muscle and their peak latencies 
found to increase with increasing stimulus duration. 
The bone conduction (BC) stimulus reflects the combined otolith 
projection to the neck 112.  Ipsilateral responses were found to be larger 113 for 
the BC delivered via the mastoid. Lower frequencies are required to produce 
BC VEMPs and a larger response can be obtainted at or below 100Hz111. 
Similar contralateral crossed response has been found with cathodal 
galvanic stimulation GVS114. Sometimes an ipsilateral crossed response or an 
absent response was recorded with anodal stimulation by Watson115 
 
2.9. TECHNICAL PITFALLS IN DOING VEMPS: 
• Less availability of studies 
• Relatively new test 
• No protocol and quality assurance. 
Hence the concern is to standardize the method according to the population. 
 
A.) assuring neck muscle activation - biggest problem!140: 
Assuring neck muscle activation is a big crisis mainly for two reasons: 
• head held up against gravity 
• test should be repeated twice to ensure reliability. 
• Less comfortable and cant be sustained for longer time. 
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Although fatiguing only one SCM with the head turned one sided is 
possible, smaller potentials are produced with less reliable results. 
An intrinsic problem arises in case of very young children as it needs  
continuous co-operation.  
 
B.) Thresholds levels at 500Hz is maintained to produce reliable VEMP121. 
C.) Electrical artefact: 
• sound generators near electrodes 
• higher impedance  
• improper placement of electrodes  
• nearby electrical activity  
These can  produce sinusoidal undulations or stimulus artefact. 
 
D.) Other artifacts: 
• Technical errors 
• improper instrumentation are to be checked. 
 
2.10.CLINICAL UTILITY OF VEMPs: 
VEMP is a promising method for diagnosing and follow up of patients 
with retrocochlear lesions, brainstem lesions and tumours of vestibular 
apparatus.  
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A. IN MENIERES DISEASE117: 
• The VEMP response is increased in early stage of Menieres 
disease due to saccular dilatation.  
• absent response in advanced cases due to collapse of the saccule. 
B. IN RETROCOCHLEAR LESIONS89,127: 
• More prolonged p13 latency seen in BPPV compared to vestibular 
neuritis and menieres disease, though their clinical findings were  
almost the same. 
• Asymmetry and long latency response was also found in 
vestibular neuritis. 
C. SPASMODIC TORTICOLLITIS116: 
• VEMPs are often asymmetrical as reported by Colebatch et al. 
D. IN BRAINSTEM LESIONS AND MULTIPLE SCLEROSIS153: 
• Shimuzu et al reported that both the latencies and the amplitude 
were prolonged in brainstem stroke , medullary lesions and 
demyelinating disorders . 
  
Aim And Objectives 
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3. AIM : 
 
  To assess vestibular evoked myogenic potential in various age groups 
and compare it with migraine patients. 
 
3.1. OBJECTIVE : 
             1.  To quantify the physiologic changes which occur in the vestibular 
(specifically saccular pathways) system with aging utilizing the VEMP. 
 2.   To compare vestibular evoked myogenic potentials between two 
different modes of neck torsion 
              (i) lifting head forwards towards centre and 
              (ii) lifting head and simultaneously turning away from the ear of  
                   stimulus. 
           3. To evaluate whether the influence of inverting electrode at different 
sites on the VEMP parameters. 
4. To investigate VEMPs in patients with migraine and to compare it 
with that of age and sex matched controls. 
 
 
 
 
  
 Materials And Methods 
 
 
 
 
 
 
 
 
4.MATERIALS 
AND 
METHODS 
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4. MATERIALS AND METHODS: 
 
The study was conducted in the Institute Of Physiology And 
Experimental Medicine, Madras Medical College, Chennai-3. The study 
protocol was approved by our Institutional Ethical Committee, Madras 
Medical College, Chennai. The subjects participating in this study were 
informed about the study and written consent was obtained from them before 
including them in the study. 
  
4.1. STUDY DESIGN:  It is a cross-sectional study. 
Number of groups : Two. 
 
4.2. INCLUSION CRITERIA: 
4.2.1. Controls: 
Age and sex : 17 years to 70 years of both sex. 
Without otologic and neurologic diseases. 
4.2.2. Cases: 
According to the international headache society ICHS-2 criteria patients 
who fulfilled the criteria for classical migraine and definite or probable 
vertiginous migraine were included in this study. 
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4.3. EXCLUSION CRITERIA: 
1. Subjects with conductive deafness either due to ear pathology or any 
other systemic disorders  
2. History of hypertension or diabetes 
3. Any neurologic disorder or metabolic disorder. 
4.4. SELECTION OF SUBJECTS: 
4.4.1. Cases: 
50 patients with migraine were selected from the headache outpatient 
department, Institute of neurology, Madras Medical College, Chennai who 
fulfilled the ICHS criteria for migraine and definite or probable migrainous 
vertigo.  
4.4.2. Controls: 
100 clinically healthy adult volunteers were enrolled as control group in 
this study. The control group were either the attendants of the migraine 
patients of RGGH or the students and staff of Madras medical college who 
attended the study voluntarily. 
          From the control group,   
1. 80 healthy adult volunteers  were involved to study the effect of age 
on VEMP parameters;  
2. 25 of the 80 healthy adult volunteers in the age group of 17 to 26 
years were involved in the study on the different modes of neck torsion on 
VEMP parameters.   
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3. Another 20 healthy adult volunteers of 17 to 26 years were involved 
to study the influence of reference or inverting electrode placement on VEMP 
parameters; 
4.5. PREPARATION OF SUBJECTS: 
STEP 1: Before subjecting to the tests all subjects were examined 
clinically and the experimental procedure was explained to them in the 
language that they could understand. An adequate time was given to the 
subjects to get accustomed to the new settings.    
STEP 2: Hearing normality was assessed with otoscopy and pure-tone  
               audiometry  
STEP 3: they were then subjected to VEMP  test using RMS 
multichannel polyrite. 
The test was done in single session lasting approximately 20 minutes. 
During the period of testing, participants were given adequate rest periods to 
reduce fatigue and boredom. The subjects were asked to lie in supine position 
on the table and the electrodes  placed using standard gel (for good 
conduction) after wiping the area with spirit.  
A.) Placement Of Electrodes: 
-  Ground electrode is placed on the forehead(Fz). 
-  Reference (inverting) electrode is placed over the sternum. 
-  Non-inverting or the active electrode is placed over the middle third of    
  the (SCM) sternocleidomastoid muscle. 
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B.)  Stimuli used for recording VEMP: 
VEMP recording was initiated when the acoustic stimuli were given as 
loud air-conducted (AC) sound of  short tone bursts 500 HZ via biologic 
standard RMS headphones (DR-531, RMS MULTIPOLYRITE). The stimulus 
was presented with rarefaction polarity, two cycles plateau with one cycle rise 
and fall times. The stimulation rate was 5Hz/sec  and the analysis time for 
each response was 100 ms and 150 responses were averaged for each run. 
EMG (electromyogenic) activity was recorded both from the ipsilateral and 
contralateral  Ag/AgCl surface electrodes placed over the middle part of the 
sternocleidomastoid  SCM muscle . The EMG activity was amplified 5000 
times and band pass filtered 20Hz-2000Hz.   
PARAMETERS SELECTION 
• STIMULUS  
1. Transducer Biologic standard RMS headphones 
2. Type 500Hz short tone bursts 
3. Ramping Blackman 
3.1. Duration 2 cycles plateau; 1 cycle rise/fall 
4. Intensity 95-100 dB Nhl  
5. Polarity Rarefaction 
6. Rate 5Hz 
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• ACQUISITION  
1. Analysis time  
1.1.  Epoch time  100 ms 
2. Electrode type  Surface (Ag/Agcl) 
3. Electrode location  
3.1. ground electrode Forehead 
3.2. inverting electrode Sternum 
3.3. non-inverting electrode Middle third of SCM muscle 
4. Band pass filtered  20Hz-2000Hz 
5. Amplification 5000 times 
6. Averaged for each run 150 presentations. 
 
C.) Procedure of  VEMP recording: 
  Subjects were placed in the supine position. After the auditory click was 
given subjects were asked to activate their SCMs by lifting their heads 
forwards towards the centre. They were then asked to maintain adequate levels 
of tonic neck activation during the recording. Auditory stimulus was given 
binaurally and monoaurally. The vestibular evoked myogenic potential 
response was recorded both from the ipsilateral and contralateral SCM muscle 
both during binaural and monoaural stimulation.   
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In 20 subjects among the control group , the reference or inverting 
electrode was also placed at three different sites like sternum, wrist and the 
mastoid and the VEMP responses were recorded .  
In 25 subjects among the control group, VEMP was recorded using two 
modes of neck torsion like 
- Lifting Head Forwards Towards Centre. 
- Lifting head and simultaneously turning away from the ear of 
stimulus  
After the recordings were complete, the surface electrodes were 
removed and the recording paste was wiped with spirit and water. 
 
4.6. VEMP RESPONSES 
The recorded VEMP showed the following waveforms:  
1. The p13 latency -  defined as the positive polarity of the biphasic 
wave that appears at approximately 13 ms  
2. The n23 latency -  defined as the negative polarity of the biphasic 
wave that appears at approximately 23 ms.  
3.The p13-n23 amplitude -  defined as the peak-to-peak p13-n23 
maximum energy in µV.  
4.VEMP asymmetry ratio (VAR) or inter amplitude ratio (IAD) is 
defined as the ratio of the inter-aural amplitude difference to the sum of the 
amplitudes of both ears. 
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5. RESULTS 
 
5.1.STATISTICAL ANALYSIS: 
The VEMP recordings were conducted on 100 clinically healthy 
individuals (CONTROLS) and 50 patients with migraine (STUDY GROUP) . 
The recorded VEMP responses from the control and the migraine study group 
were statistically analysed and their significance were determined using SPSS 
for windows under the following headings: 
1. Analysis of the anthropometric details between the control and the 
migraine group by using unpaired students ‘t’ test. 
2. Normative data of VEMP in different age groups in the control 
population by using unpaired students ‘t’ test. 
3. Comparison of two modes of neck torsion in the control group by using 
unpaired students ‘t’ test. 
4. Comparison of the different placements of inverting or reference  
electrode  in the control group by One way Analysis Of Variance 
followed by tukeys multiple comparison tests. 
5. Comparison of migraine patients with/without vertigo  with age and sex 
matched controls by using unpaired students ‘t’ test. 
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5.2.ANALYSIS OF THE ANTHROPOMETRIC DETAILS BETWEEN 
THE CONTROL AND THE MIGRAINE GROUP. 
 
The  anthropometric measures like age, height, weight, BMI of the 
controls and the migraine subjects were subjected to students unpaired  ‘t’ test. 
No significant change  was found for the  controls and the migraine 
study group and they were found to be suitable for this comparative study. The 
anthropometric parameters of  the control group and the migraine patients 
were tabulated in table 1. 
 
Table1: Anthropometric measures of the control group and  
the migraine patients 
 
STUDY GROUP AGE 
Mean ± 
SD 
HEIGHT 
Mean ± SD 
WEIGHT 
Mean ± SD 
BMI 
Mean ± SD 
Control  group 
N=100 
38.9 ± 15.9 162.2 ± 8.03 62 ± 8.8 23.7 ± 3.8 
Migraine patients 
N-50 
34.7 ± 11.3 167.2 ± 5.08 68.95 ± 7.6 24.64 ± 2.04 
‘p’ value 0.1 # 0.7 # 0.3 # 0.3 # 
 
#  not significant 
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5.3. NORMATIVE DATA OF VEMP IN DIFFERENT AGE GROUPS IN 
THE CONTROL POPULATION: 
 
80 healthy individuals from the control group consisting of 40 males and 
40 females in the age group between 17 and 70 years (mean 38.9 ± 15.93) 
were subjected to VEMP and their results were statistically analysed to derive 
significance using appropriate students t test.  The mean height(cm), weight 
(kg) and BMI (cm/kg) of the control  group was found to be 162.2 ± 8.03, 
61.98 ± 8.75, 23.7 ± 3.8 respectively. The p13 latency, n23 latency and p13-
n23 amplitude of the VEMP response among different age groups has been 
tabulated in table 2. 
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Table 2: Comparison of p13 and n23 latencies, p13-n23 amplitude  
among different age groups. 
AGE GROUPS p 13 LATENCY 
(ms) 
n 23 LATENCY 
(ms) 
p13 - n23 
AMPLITUDE 
(µV) 
17 – 20 11.7 ± 1.7 21.8 ± 3.3 44.14 ± 8.8 
21 – 30 11.7 ± 1.5 21.7 ± 3 45.9 ± 6.1 
31 – 40 11.7 ± 1 21.8 ± 2.4 1.2 ± 5.5 
41 – 50 11.7 ± 1.2 21.8 ± 2.1 40.4 ± 4.6 
51 – 60 11.6 ± 1 21.3 ± 1.8 30.1 ± 5.9  * 
61 – 70 11.6 ± 1 21.3 ± 1.8 19.2 ± 3.2 * 
Mean values 11.7 ± 1.2 21.6 ± 2.4 38.49 ± 5.7 
 
*significant  with p value <0.05.  
 
5.3.1. P13 LATENCY: (ms) 
The mean p13 latency remained to be  consistent across the age group 
from 17-70 years with the mean value of  11.7 ± 1.2 and no significant 
differences was observed between the different age groups.(Table 2, Figure 2). 
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5.3.2. N23 LATENCY: (ms) 
The mean n23 latency were remained to be consistent across the age 
group from 17-70 years with the mean value of  21.6 ± 2.4 and no significant 
differences was observed between the different age groups.(Table 2, Figure 3) 
 
5.3.3. P13-N23 AMPLITUDE: 
The mean p13- n23 amplitude showed a significant decline (p<0.001) in 
the amplitude above 50 years of age.(Table 2, Figure 4). 
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Figure 2: 
 
Figure 3: 
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Figure 4: 
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5.2.4. INTER-AMPLITUDE DIFFERENCE RATIO (IAD %) : 
The interamplitude difference ratio was calculated using the formula 
[(AR-AL) / (AR+AL)]  X  100, where  AR = amplitude of the right ear. AL = 
amplitude of the left ear. 
The interamplitude difference ratio was higher above 50 years of age but 
showed no significance.(Table 3). 
Table 3: Comparison of Interamplitude difference ratio during  
binaural (B/L) and monoaural (U/L) stimulation in different age groups. 
Age 
Groups 
In Years 
IAD B/L 
MEAN ± 
SD 
IAD U/L 
MEAN ± SD 
‘P’ 
VALUE 
IAD % 
B/L 
IAD % 
U/L 
17 – 20 0.6 ± 5 -0.4 ± 4.1 0.3 # 8 6 
21 – 30 -2 ± 5.2 1.7 ± 2.4 0.1 # 6 6 
31 – 40 -0.7 ± 4.9 1.3 ± 3.1 0.1 # 8 7 
41 – 50 1.4 ± 5.5 0.9 ± 5 0.5 # 9 7 
51 – 60 2.1 ± 7.5 1.5 ± 6.4 0.4 # 12 11 
61 – 70 4.5 ± 6.2 2.2 ± 8.1 0.2 # 16 12 
  
#  not significant 
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5.4.COMPARISON OF TWO MODES OF NECK TORSION IN THE 
CONTROL GROUP: 
 
25 healthy individuals of 17 to 26 years from the control group 
consisting of 11 males and 14 females with mean age of (20.9 ± 3.1) years  has 
been involved  for studying the comparison between two modes of neck 
torsion to produce reliable VEMP,   
(i) Lifting head forwards towards centre                                            
(ii) Lifting the head forward and turning to the side away from the 
source of stimulus.  
The results were statistically analysed and their significance determined 
using appropriate students ‘t’ test . 
 
5.4.1. P13 LATENCY: 
5.4.1.1. Comparison of p13 latencies between two modes of neck torsions: 
Table 4: Comparison of p13 latencies between two modes of neck torsions 
MODE OF NECK TORSION 
RIGHT EAR 
p13 latency 
(ms) 
LEFT EAR 
p13 latency 
(ms) 
 
‘p’ 
value 
Head lifted towards centre 11.8 ± 1.3 11.7 ± 1.2 0.4 
Head lifted and turned away from 
source of stimulus 
11.7 ± 1.3 11.7 ± 2 0.5 
‘p’ value 0.4 # 0.5 # - 
 
#  not significant 
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No significant difference in mean p13 latency was observed between 
two modes of neck torsion for both the ears.(Table 4,Figure 5). 
 
5.4.2. N23 LATENCY: (ms)  
5.4.2.2. Comparison of n23 latencies between two modes of neck torsion: 
Table 5: Comparison of n23 latencies between two modes of neck torsion 
MODE OF NECK TORSION RIGHT 
EAR n23 
latency (ms) 
LEFT EAR 
n23 latency 
(ms) 
‘p’ 
value 
HEAD LIFTED TOWARDS 
CENTRE 
 
21.6 ± 2.6 
 
21.8 ± 3.4 
 
0.4 # 
HEAD LIFTED AND TURNED 
AWAY FROM SOURCE OF 
STIMULUS 
 
21.7 ± 1.9 
 
21.7 ± 1.7 
 
0.5 # 
‘p’ value 0.4 # 0.5 # - 
 
#  not significant 
No significant difference in mean p13 latency was observed between 
two modes of neck torsion for both the ears. (Table 5,Figure 6). 
 
  
Figure 5: 
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5.4.3.P13-N23 AMPLITUDE: (µV): 
5.4.3.1. Comparison of p13-n23 amplitude between two modes of 
neck torsion: 
Table 6: Comparison of p13-n23 amplitude between two modes of 
neck torsion. 
MODE OF NECK TORSION 
RIGHT 
EAR p13-
n23 (µV) 
LEFT EAR 
p13-n23 (µV) 
‘p’ 
value 
HEAD LIFTED TOWARDS 
CENTRE 
 
43.9 ± 7 
 
43.9 ± 6.8 
 
0.5 # 
HEAD LIFTED AND TURNED 
AWAY FROM SOURCE OF 
STIMULUS 
49.7 ± 7.5 49.5 ± 7.3 0.5 # 
‘p’ value 0.003 * 0.003 * - 
 
#  not significant , *  highly significant with p value >0.05 
 
A highly significant increase in p13-n23 amplitude of the VEMP 
response was seen for both the ears while lifting head forward and turned to 
the side away from the source of stimulus , (p = 0.003 for right ear and 
p=0.003 for left ear ).(Table 6,Figure 7). 
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5.4.4. INTERAMPLITUDE DIFFERENCE RATIO : 
Table 7: Comparison of Interamplitude difference ratio between  
two modes of neck torsion. 
STUDY GROUP 
IAD U/L 
Mean ± SD 
IAD % U/L 
Head towards centre 0.1 ± 3.9 6 
Head turned away from stimulus 0.3 ± 3.6 7 
‘p’ value 0.4 # - 
 
#  not significant 
 
No significant change was observed in the interamplitude difference 
ratio between the two modes of neck torsion.(Table 7). 
 
5.5. COMPARISON OF THE DIFFERENT PLACEMENTS OF 
INVERTING/ REFERENCE ELECTRODE  IN THE CONTROL 
GROUP.  
 
20 healthy individuals in the age group of 17-26 years from the control 
group (mean 21±3.1) were assessed for the influence of inverting electrodes on 
the VEMP waveforms. The reference or inverting electrodes were  placed at 
different sites such as sternum, mastoid and the wrist; and the VEMP response 
were statistically analysed and their significance derived using one way 
ANOVA followed by Tukeys multiple comparison tests. 
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5.5.1. P13 LATENCY: 
The p13 latency during binaural stimulation of the VEMP response 
showed no significant difference (df=2, F=3.96 for right, df=2, F=8.5 for left) 
when reference electrodes were placed at the sternum, mastoid or the wrist . 
(Table 8,Figure 8).  
The p13 latency during monoaural stimulation of the VEMP response 
showed no significant difference (df=2, F=4.1 for right, df=2, F=4.3 for left) 
when reference electrodes were placed at the sternum, mastoid or the wrist. 
(Table 8,Figure 8).  
No significant change was observed during binaural and monoaural 
stimulation. 
Table 8: Comparision of p13 latency among different    
placement of  electrodes 
P13 LATENCY Sternum Wrist Mastoid 
B/L         LT 12.9±0.7 11.9±0.9 12.1±0.7 
B/L         RT 12.5±1.5 11.7±0.8 11.7±0.8 
RT 12.9±1.2 11.6±2.2 11.9±1.1 
LT 12.7±0.9 12.1±0.9 12.2±0.7 
 
5.5.2. N23 LATENCY: 
The n13 latency during binaural stimulation of the VEMP response 
showed no significant difference (df=2, F=4.04 for right, df=2, F=2.9 for left) 
when reference electrodes were placed at the sternum, mastoid or the wrist . 
(Table 9,Figure 9).  
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The n13 latency during monoaural stimulation of the VEMP response 
showed no significant difference (df=2, F=1.6 for right, df=2, F=4.945 for left) 
when reference electrodes were placed at the sternum, mastoid or the wrist. 
(Table 9,Figure 9). 
No significant change was observed during binaural and monoaural 
stimulation. 
Table 9:Comparision  of n23 latency among different placement  
of electrodes 
N23 Shernum wrist Mastoid 
B/L         LT 22.3±1.7 20.9±2.2 21.7±1.7 
B/L         RT 22.5±2.5 20.2±3.2 21.9±2.8 
RT 22±2.3 20.9±1.8 21.3±2.3 
LT 22.6±1.5 20.4±3.2 21.5±2.2 
 
5.5.3. P13-N23 AMPLITUDE: 
The p13 latency during binaural stimulation of the VEMP response 
showed no significant difference (df=2, F=6.6 for right, df=2, F=7.6 for left) 
when reference electrodes were placed at the sternum, mastoid or the wrist . 
(Table 10,Figure 10).  
The p13 latency during monoaural stimulation of the VEMP response 
showed no significant difference (df=2, F=7.7 for right, df=2, F=4.2 for left) 
when reference electrodes were placed at the sternum, mastoid or the wrist. 
(Table 10,Figure 10).  
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A significant increase (p<0.001) in amplitude was found when the 
inverting electrode was placed in the sternum compared to that of the wrist or 
mastoid. 
Table 10: Comparison of p13-n13 amplitude among different  
placement of electrodes. 
P13-
n23amplitude Shernum Wrist Mastoid 
B/L         LT 53.4±4.1 51.1±4.8 51.9±3.6 
RT 55.2±4.6 50.5±4.7 52.1±4.2 
RT 54.9±4.1 49.9±4.5 51.6±4.3 
LT 55.1±5 51.2±4.3 52.1±5 
 
5.5.4. INTERAMPLITUDE DIFFERENCE RATIO: 
Table 11: Comparison of interamplitude difference ratio among  
different placement of electrodes. 
 
 
STUDY 
GROUP 
IAD B/L 
Mean ± 
SD 
IAD U/L 
Mean ± SD 
 
IAD % B/L 
 
IAD % U/L 
sternum -0.1 ± 1.5 -0.1 ± 3 6 2 
wrist -0.5 ± 1.6 -1.3 ± 2.5 5 3 
mastoid 0.2 ± 1.5 -0.5 ± 2 4 4 
 
No significant change was observed in the interamplitude difference 
ratio among different placement of electrodes. 
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Figure 8: 
 
 
Figure 9: 
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Figure 10: 
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5.6.COMPARISON OF MIGRAINE PATIENTS WITH AND WITHOUT 
VERTIGO WITH AGE AND SEX MATCHED CONTROLS : 
 
As per the ICHS-2 , the study group of 50 migraine patients were further 
classified into two groups 
1. those with migraine alone (n=20) and  
2. those who had vertigo associated with migraine (n=30).  
The results were statistically analysed for their significance using 
appropriate students t test. 
 
5.6.1.MIGRAINE PATIENTS WITHOUT VERTIGO COMPARED WITH 
AGE-SEX MATCHED CONTROLS. 
20 patients had definite migraine without vertigo were compared with 
age and sex matched controls. Unpaired students ‘t’ test used to compare the 
mean latencies and amplitudes of VEMP between the control and the migraine 
patients. 
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5.1.1. P13 LATENCY : (ms) 
TABLE 12: Comparison of  p13 latency between the control and the 
migraine patients without vertigo. 
P13 latency 
(ms) 
Bilateral 
left 
Mean±SD 
Unilateral 
left 
Mean ±SD 
 
‘p’ 
value 
Bilateral 
right 
Mean±SD 
Unilateral 
right 
Mean ±SD 
 
‘p’ 
value 
 Control group 
n=50 
 
11.84  
± 2.2 
 
11.82 ± 1.4 
 
0.5 
 
11.8 ± 1.6 
 
11.94 ± 1.2 
 
0.4# 
Migraine 
patients n=50 
 
11.73 ± 1 
 
11.7 ± 1.1 
 
0.5 
 
11.83 ± 
1.5 
 
11.94 ± 1.1 
 
0.4# 
‘p’ value 0.4# 0.4# - 0.5# 0.5# - 
 
#  not  significant 
There was no statistically significant difference in p13 latency observed  
between the control  and migraine patients without vertigo. (Table 12,Figure 
11). 
No significant difference in p13 latency between binaural and 
monoaural stimulation was found between controls and migraine 
patients.(Table 12,Figure 11). 
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5.6.1.2.N23 LATENCY : (ms) 
Table 13 : Comparison of n23 latency between the control and  
migraine patients without vertigo. 
N23 
latency 
(ms) 
Bilateral 
left 
Mean±SD 
Unilateral 
left 
Mean ±SD 
 
‘p’ 
value 
Bilateral 
right 
Mean±SD 
Unilateral 
right 
Mean ±SD 
 
‘p’ 
value 
 Control 
group 
n=50 
 
20.4 ± 2.6 
 
21.7 ± 2.2 
 
0.06 
 
21.8 ± 2.3 
 
20.8 ± 1.4 
 
0.07 # 
Migraine 
patients 
n=50 
 
20.8 ± 2.6 
 
21.8 ± 3 
 
0.1 
 
21.7 ± 1.6 
 
20.9 ± 2.1 
 
0.08 # 
 
‘p’ value 
 
0.3 # 
 
0.4 # 
 
- 
 
0.5 # 
 
0.5 # 
 
- 
 
#  not  significant 
There was no statistically significant difference in n23 latency observed  
between the control  and migraine patients without vertigo. 
No significant difference between binaural and monoaural stimulation 
was found between controls and migraine patients without vertigo.(Table 13, 
Figure 12.). 
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Figure 11: 
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5.6.1.3.P13-N23 AMPLITUDE : 
Table 14: Comparison of p13-n23 amplitude between the control  
and the migraine patients without vertigo. 
p 13 - n23 
amplitude 
(µV) 
Bilateral 
left 
Mean±SD 
Unilateral 
left 
Mean ±SD 
 
‘p’ 
value 
Bilateral 
right 
Mean±SD 
Unilateral 
right 
Mean ±SD 
 
‘p’ 
value 
Control 
group 
n=50 
 
42 ± 6.4 
 
42.8 ± 8 
 
0.4 # 
 
42.2 ± 4.7 
 
43.02 ± 6.8 
 
0.3 # 
Migraine 
patients 
n=50 
 
24.4 ± 8.1 
 
22.3 ± 6.6 
 
0.2 # 
 
24.03 ± 
8.5 
 
23.7 ± 7.8 
 
0.4 # 
‘p’ value 1.6E-09 * 3.93E-11 * - 1.77E-10 * 1.79E-10 * - 
 
#  not  significant ; * highly significant p value <0.05. 
 
A highly significant decrease in amplitude was found between the 
migraine patients without vertigo and the control group (p<0.001)  both during 
binaural stimulation (p=1.6E-09 for left ear, p=1.77E-10 for right ear) and 
monoaural stimulation (p=1.79E-10 for right ear, p=3.93E-11 for left ear). 
(Table 14,Figure 13). 
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Figure 13: 
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5.6.1.4.IAD RATIO (%) : 
Table 15: Comparison of IAD ratio between the control and the migraine 
patients without vertigo. 
 
STUDY GROUP 
IAD 
binaural 
stimulus 
Mean ± SD 
IAD 
monoaural 
stimulus 
Mean ± SD 
IAD % 
binaural 
stimulus 
IAD % 
monoaural 
stimulus 
Controls 0.6 ± 5 0.5 ± 5.4 12 7 
Migraine patients 
without vertigo 
 
-0.6  ± 14.2 
 
2.5 ± 8.6 
 
19 
 
14 
‘p’ value 0.3 # 0.1 # - - 
 
# not significant 
 
The interamplitude difference ratio during binaural stimulation was 19%  
in the migraine patients without vertigo and 12 % in the control group. No 
significance was observed for the increased IAD% in migraine patients. 
The interamplitude difference ratio during monoaural stimulation was 
14%  in the migraine patients without vertigo and 7 % in the control group. No 
significance was observed for the increased IAD% in migraine patients. (Table 
15).  
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5.7.MIGRAINE PATIENTS WITH VERTIGO COMPARED WITH 
AGE-SEX MATCHED CONTROLS.(N=30). 
 
30  migraine patients with vertigo were  compared with age and sex 
matched controls. Unpaired students ‘t’ test  was used to compare the mean 
latencies and amplitudes of VEMP between the control and the migraine 
patients. 
 
5.7.1.P13 LATENCY  (ms): 
Table 16: Comparison of p13 latency between the control and the  
migraine patients with vertigo. 
P13 latency 
(ms) 
Bilateral 
left 
Mean±SD 
Unilateral 
left 
Mean 
±SD 
 
‘p’ 
value 
Bilateral 
right 
Mean±SD 
Unilateral 
right 
Mean 
±SD 
 
‘p’ 
value 
 Control group 
n=30 
 
11.8 ± 2.2 
 
11.9 ± 1.3 
 
0.4 # 
 
11.9 ± 1.7 
 
11.9 ± 1.3 
 
0.5 # 
Migrainous 
vertigo  patients 
n=30 
 
11.9 ± 1.7 
 
11.9 ± 1.3 
 
0.5 # 
 
11.9 ± 1.4 
 
11.8 ± 2.5 
 
0.4 # 
‘p’ value 0.4 # 0.5 # - 0.4 # 0.4 # - 
 
#  not significant 
There was no statistically significant difference in p13 latency between 
the controls and migraine patients with vertigo. (Table 16,Figure 14). 
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5.7.2.N23 LATENCY : (ms) 
Table 17: Comparison of n23 latency between the control and the migraine 
patients with vertigo. 
n23 
latency 
(ms) 
Bilateral 
left 
Mean±SD 
Unilateral 
left 
Mean ±SD 
 
‘p’ 
value 
Bilateral 
right 
Mean±SD 
Unilateral 
right 
Mean ±SD 
 
‘p’ 
value 
 Control 
group n=50 
 
21.8 ± 3.3 
 
21.9 ± 2.6 
 
0.4 # 
 
21.9 ± 2.8 
 
21.7 ± 2.6 
 
0.4 # 
Migraine 
patients 
n=50 
 
21.8 ± 2.4 
 
21.7 ± 4.7 
 
0.5 # 
 
21.7 ± 2.6 
 
21.8 ± 2.4 
 
0.5 # 
‘p’ value 0.5 # 0.4 # - 0.4 # 0.5 # - 
 
#  not significant 
 
There was no statistically significant difference in n23 latency between 
the controls and migraine patients with vertigo.(Table 14,Figure 15). 
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Figure 14: 
 
Figure 15: 
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5.7.3.P13-N23 AMPLITUDE : 
Table 18 : Comparison of p13-n23 amplitude between the controls and the 
migraine patients with vertigo. 
p 13 - n23 
amplitude 
(µV) 
Bilateral 
left 
Mean±SD 
Unilateral 
left 
Mean ±SD 
‘p’ 
val
ue 
Bilateral 
right 
Mean±SD 
Unilateral 
right 
Mean ±SD 
 
‘p’ 
value 
Control group 
n=50 
 
39.7 ± 9.2 
 
39.9 ± 8 
 
0.5 
 
39.9  ± 9.5 
 
41.3 ± 8.9 
 
0.3 # 
Migraine 
patients n=50 
 
22.5 ± 7.5 
 
22.5 ± 7.1 
 
0.5 
 
22.5  ± 7.2 
 
22.7 ± 8.4 
 
0.5 # 
‘p’ value 3.13E-11 * 8.12E-13 * - 2.78E-11 * 1.72E-12 * - 
 
# not significant, * highly significant with p value >0.05 
 
A highly significant decrease (p<0.001) was found between the control 
group and the migraine patients with vertigo (Table 15,Figure 16). 
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Figure 16: 
 
 
 
 
 
 
 
0
5
10
15
20
25
30
35
40
45
B/L LT B/L RT RIGHT LEFT
A
M
PL
IT
U
D
E 
 
in
 
 
µ 
V
EAR OF STIMULUS
COMPARISON OF p13-n23 AMPLITUDE BETWEEN 
CONTROLS AND MIGRAINOUS VERTIGO  PATIENTS
CONTROL GROUP MIGRAINOUS VERTIGO PATIENTS
73 | P a g e  
 
5.7.4. INTERAMPLITUDE DIFFERENCE RATIO %: 
Table 19: Comparison of interamplitude difference ratio between the 
controls and migraine patients with vertigo. 
STUDY GROUP IAD B/L 
Mean ± 
SD 
IAD U/L 
Mean ± SD 
IAD % 
B/L 
IAD % 
U/L 
Controls 0.03 ± 8.7 1.4 ± 4.8 16 11 
Migraine patients 
with vertigo 
0.3  ± 9 -0.3 ± 9 17 11 
‘p’ value 0.5 # 0.2 # - - 
 
#  not significant 
 
The interamplitude difference ratio during binaural stimulation was 17%  
in the migraine patients with vertigo and 16 % in the control group and no 
significant change was observed.(Table 19). 
 
The interamplitude difference ratio during monoaural stimulation was 
11%  in the migraine patients with vertigo and 11 % in the control group and 
no significant change was observed. (Table 19).  
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6. DISCUSSION 
 
Vestibular evoked myogenic potential (VEMP) test is an useful tool in 
determining whether the saccule, inferior vestibular nerve and central 
connections are intact and working normally. The saccule which is an organ of 
hearing in lower animals has a slight sound sensitivity and this is measured in 
VEMP testing. 
141Sound stimulates the saccule which activates the inferior nerve, lateral 
vestibular nucleus , 11th cranial nerve nucleus and then the ipsilateral SCM 
mostly through the medial vestibulospinal tract. The main source of VEMP is 
saccule141. This study on VEMP was performed on migraine patients and 
compared with age and sex matched controls. 
1. The controls were studied for the following: 
A.) effect of age on VEMP response. 
B.) Effect of two different modes of neck torsion on VEMP response. 
C.) Effect of placement of reference/inverting electrode at different sites 
namely sternum, mastoid and wrist on VEMP response. 
2. VEMP response on migraine patients with or without vertigo were then 
compared with age and sex matched controls. 
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6.1 SOUND STIMULUS AND PRESENTATION: 
 
To get a VEMP response loud clicks of 80-120dB were repetitively 
presented to each ear in turn at 20msec intervals (5/sec) with an optimum 
frequency of 500Hz using sternum as reference and the forehead as the 
ground. The myogenic potential are  amplified , band pass filtered (30-3KHZ) 
and analyzed for 200 presentations. The response evoked from the mid portion 
of  SCM are averaged and presented as VEMP. The latencies p13 , n23 and  
p13-n23 amplitudes and interamplitude difference are to be measured. 
 
VEMP can also be elicited by tone bursts of 500 or 1000hz at 5/sec rate 
of 120dB SPL. The advantage of tone bursts is that it requires lower stimulus 
intensities107 . 
 
In our study we have used loud clicks of 100 dB which were averaged 
for 200 presentations with a minimum of two repetitions to elicit a VEMP 
response using RMS multichannel polyrite.  
 
6.2.BINAURAL / MONOAURAL STIMULATION OF VEMP: 
 
VEMP can be elicited by binaural and/or monoaural stimulation. There 
are different schools of thought regarding the type of stimulus to be used. 
141
“Monoaural stimulation produces a healthy response compared to 
binaural since VEMPs are generally ipsilateral”  because binaural stimulation 
may produce a “volume conduction” artefact when the electrical activity 
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crosses the midline. Binaural stimulus is faster but it reduces the ability to 
localize the side of lesion due to cross over unlike the work done by yang et 
al142.   
In our study we have used both binaural and monoaural stimulation and 
the elicited VEMP response  did not show much variation. 
 
6.3. LATENCIES p13 AND n23 (ms): 
 
The latencies of p13 and n23 in our study did not significantly vary with 
regard to the different types of neck torsion or to the placement of the inverting 
electrodes. Similarly the latencies did not alter either with age or with the 
study group namely the migraine patients. As per 141timothy et al the 
usefulness of measuring latencies is of less significance since it is less reliable. 
The only usefulness it has, is in deciding whether a particular waveform is a 
‘VEMP’ or just noises. 
People with fat neck have lower responses as the signal from the muscle 
is underneath the fat and has to go a longer distance. Similarly people with 
longer neck have later responses as the signal again has to go a longer 
distance104. 
Prolonged latency of VEMP indicateretrocochlear lesions such as 
vestibular neuritis. Abnormal asymmetrical or long latencies were also 
reported by 143Murofuschi et al 1996 in about 25% of patients with vestibular 
neuritis. 
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Prolonged latencies are also seen in persons with long neck . Sometimes 
‘VEMP’ like potentials that is caused by posterior auricular muscles (PAM) 
occur at a latency of 11ms which might overlap VEMP or it might be due to 
volume conduction. This can be ruled out by running VEMP initially or 
inbetween other runs without contracting SCM144,145. 
 
6.4. AMPLITUDE (µV) : 
 
The most reliable parameter of the VEMP response is the amplitude121. 
The limits of normal for the amplitude for the head rising technique are 
roughly between 70-700141.  Except persons with hyperacussis who shows 
longer amplitude , most of the diseases are diagnosed with values lesser than 
the upper limit. 
In our study the amplitude were within the normal range in controls as 
well as in migraine patients. The mode of neck torsion and the placement of 
reference electrode or the age had no bearing on the amplitude regarding the 
normal range. However significant increase in the amplitude was seen when 
the neck was lifted forwards and the neck turned away from the source of 
stimulus. Similarly a significantly larger amplitude was seen when the 
reference electrode was placed on the sternum compared to the wrist or the 
mastoid .With regard to age there was a significant drop in the amplitude after 
50 years of age in our study.  
78 | P a g e  
 
Other mode of neck torsion where the head is being actively turned to 
one side produces smaller potentials and are less reliable146. Some experts on 
their personal communication has recommended simply tilting the entire body 
up by 30 degrees but there are not much references for this procedure 
regarding amplitude147. 
120With regard to placement of reference /inverting electrode, li et al 
1999 had advocated wrist as the better choice for eliciting a good amplitude. 
Devon hale  identified mastoid for the same. 
Regarding the influence of age in VEMP 120su et al 2004 showed 
decreased amplitude (roughly a factor of 2)  in persons of 70 years and older 
compared to younger individuals. 148Ochi also reported amplitude of 
approximately 250 for younger age group and 90 for 80 years old. Presently it 
appears that VEMP amplitude declines as age advances. This decline is being 
much more in the elderly due to the physiological process of aging resulting in 
conductive hearing loss either due to otosclerosis or other related disorders. 
Even a small amount of hearing loss such as 10-15dB do not produce VEMP 
as reported by wang and yang 2007128. They attributed this effect to saccular 
damage. Similarly 149zhou et al reported a reduction in VEMP response in 
children with sensorineural hearing loss probably due to saccular damage 
whereas 150wu and yang 2002 identified normal VEMP in sudden hearing loss. 
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6.5.VEMP AND MIGRAINE: 
 
As per the study by 151Lia LJ et al 10 of the 20 patients with migraine 
had normal VEMP response during binaural stimulation, 7 of 20 showed 
absent VEMP response and 2 patients had delayed VEMPs. The author 
assumed the delayed and the absent VEMP are associated with brainstem 
lesions affecting the saccular pathways. whereas in our study no absent 
VEMPs were recorded and there was no significant differences between the 
latencies during binaural and monoaural stimulation. As per 109 Welgampola et 
al VEMP latencies were delayed in brainstem disorders but not in peripheral 
dysfunction whereas amplitudes depends rather on peripheral vestibular 
dysfunction. 
Our data agree with the reports of  152alen et al who stated that patients 
with migraine (without any vestibular symptoms) has VEMPs with low 
amplitudes. The author suggested that this change could be due to abnormal 
serotoninergic modulation or hypoperfusion induced ischemia to the vestibular 
nuclei.  
The reduced mean amplitude in migraine does not favour vestibular 
hyperexcitability as an explanation for the habituation deficit in migraine but 
rather an abnormal processing of repeated stimuli in the reflex circuit. 
According to the author marziyeh et al 2010 the prolonged latency of 
VEMP during the inter-attack intervals , even in the absence of vestibular 
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symptoms are suggestive of vestibular dysfunction in migraine patients. They 
also reported that there was involvement of vestibulo-spinal tract in migraine 
patients.  
In another study prolonged latency was reported in multiple sclerosis 
which were probably due to demyelination153 suggesting that latencies reflect 
the central vestibular processing.  
The question arises as to whether the reduced amplitudes in 
migrainousvertigo  is due to peripheral or central origin. Functional MRI 
studies during human migraine aura suggest that an initial cortical 
hyperperfusion is followed by a longer lasting wave of hypoperfusion154,155. 
Hyperperfusion induced cortical spreading depression (CSD)  is assumed to be 
the pathophysiologic correlate of migraine aura. Blockage of  nitric oxide 
synthesis and high levels of extracellular potassium prevents CSD 
hyperperfusion thus inducing CSD hypoperfusion that leads to infarction156. 
The origin of CSD was found to be from brainstem157 suggesting that vertigo 
symptoms might be related to hypo-perfusion induced ischemia of labrynthine 
structures158. Ischemia of the inner ear structures would reflect as reduced 
VEMP amplitude as its electrophysiologic correlate. 
Moreover many studies have reported  25% prevalence of peripheral 
vestibular abnormalities in migraine patients159. The authors reported that 
vaso-spasm induced ischemia is the cause for short-lasting vertigo attacks as 
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part of the aura and this might lead to irreversible labyrinth damage in 
migraine patients160. 
In addition, findings in migraine patients with vertigo  might be based 
on different pathomechanisms like recurrent transient ischemias, 
serotoninergic induced extravasation  causing peripheral vestibular deficits 
leading to labyrinthine signs and symptoms.  
The current data  in our study of migraine patients without vertigo 
presenting with reduced VEMP amplitudes but normal latencies point to hypo-
perfusion induced ischemia or serotoninergic induced extravasation of the 
inner ear affecting the saccule rather than the brainstem. 
On the other hand findings in migraine patients with vertigo presenting 
with more reduction of  VEMP amplitude  bilaterally signifies involvement of  
lesions in central vestibular processing. Considering that the assessment of the 
VEMPs was performed during the symptom free interval and the wide 
variation between the last migraine attack and the examination, the present 
results of reduced VEMP amplitudes during the interictal period makes it 
interesting. Thus, it seems that migraine attacks lead not only to transient 
effects but also to permanent deficits. 
Although MV is considered to be very uncommon and 
atypicalpresentation of migraine , yet it is important to recognize this 
syndrome. Since treatments are available in relieving all or most of the 
symptoms, even in subjects who are unwell for years. 
 Conclusion 
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7. CONCLUSION: 
 
VEMP a relatively new diagnostic test to assess the vestibular pathway 
was studied in relation to age , neck torsion and placement of inverting 
electrode. A sincere attempt was also made to study  the changes in VEMP in 
migraine patients with age-sex matched controls. 
 VEMP response did not show much significant change in p13 and n23 
latencies over different age groups but p13-n23 amplitude showed a significant 
decrease in the elderly which could be due to physiological degenerative 
changes of saccule and other vestibular apparatus including the vestibule-
spinal tract due to advancing age. 
Different modes of neck torsion did not produce any significant change 
in p13 or n23 latencies but there was a significant increase in p13-n23 
amplitude when the head was lifted upwards and neck turned away from the 
source of stimulus indicating that the magnitude of VEMP amplitude 
correlates with the degree of neck torsion. 
The more nearer the inverting electrode is to the active electrode greater 
is the VEMP response as evidenced by the robust amplitude seen when it was 
placed over the sternum. 
The amplitude of VEMP in migraine patients, more so in migraine 
patients with vertigo was significantly lower compared to the controls 
probably due to the habituation deficit in cortical evoked potential which 
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might be associated with hypofunction of subcortical serotoninergic input to 
vestibular nucleus. 
Although an honest attempt has been made, the study has its limitation 
since not much work has been done in the Indian sub-continent to compare the 
datas . Apart from inadequate number of subjects in the older age group a high 
level of motivation  is necessary to elicit a good and robust response . A better 
understanding of the pathophysiology of migraine would throw more light on 
the usefulness of VEMP to demarcate migraine and vertigo associated with 
migraine. Further studies is being done on the usefulness of VEMP on this 
line.  
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8. SUMMARY 
 
VEMP arelatively new diagnostic tool was studied on 50 migraine 
patients and compared with age and sex matched controls. There was no 
significant variations of p13 and n23 latencies in either the controls or the 
migraine patients. The latencies did not change with regard to the age , 
different modes of neck torsion or the placement of inverting electrodes at 
different sites. P13-n23 ampltude was significantly higher when the neck was 
lifted forwards and turned away from the source of stimulus. Similarly the 
amplitude was greater when the reference electrode was placed at the sternum 
compared to wrist and mastoid. The amplitude decreases significantly after 50 
years of age. In migraine patients with or without vertigo the amplitude 
showed a significant decrease .the magnitude of decrease in migraine patients 
was much higher.  
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PROFORMA 
ASSESSMENT OF VESTIBULAR EVOKED MYOGENIC POTENTIAL 
 
SERIAL NO: ____________    DATE: ___________ 
Name:       Age:   Sex: M / F 
MIGRAINE:   Age of onset: 
Temporal relationship:      
a) Migraine first 
b) Vertigo first 
c) Together 
 
Frequency of the attacks:    
a) Once or twice/month 
b) Once or twice/week 
c) Daily 
d) Occasional 
Severeity: 
Grade 1 : patient still able to perform normal work activity 
 Grade 2: unable to perform normal work but bed rest is unnecessary 
 Grade 3: bed rest is necessary. 
 
VERTIGO : 
Frequency of the attacks:     
a) Once or twice/month 
b) Once or twice/week 
c) Daily 
d) Occasional 
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Severeity : 
Grade 1 : patient still able to perform normal work activity 
 Grade 2: unable to perform normal work but bed rest is unnecessary 
 Grade 3: bed rest is necessary. 
 
DURATION : 
Migrainous attack -  Short.                            Vertigo attack  -   Hours  
                                  Long                                                          Minutes                
SITE   :    Bifrontal         Right Frontal          Left Frontal     
 
VESTIBULAR SYMPTOMS : 
i. Head Motion Intolerance 
ii. Positional Vertigo 
iii. Rotational Vertigo 
 
PRESENCE OF AURA:   
With Aura           Without Aura 
 
MIGRAINOUS SYMPTOMS DURING VERTIGINOUS ATTACKS 
a) Headache 
b) Phonophobia 
c) Photophobia 
d) Nausea 
e) Vomiting 
f) Visual & other auras 
 
FAMILY H/O MIGRAINE : 
H/O DRUG INTAKE  : 
H/O DM/HT   : 
H/O SMOKING : Yes / No.   H/O ALCOHOL : yes/no. 
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AUDIOLOGICAL EXAMINATION   : 
AUDIOMETRY      : 
 
EXAMINATION OF CVS   : 
 
EXAMINATION OF RS    :  
 
EXAMINATION OF CN S    :  
 
Motor system 
Sensory system 
Co-ordination 
Cranial nerve examination 
 
 
 
MIGRAINE WITH VERTIGO B/L LEFT B/L RIGHT U/L RT HR U/L LT HR
name gender AGE HEIGHT
WEI
GHT BMI P13 N23
P13-
N23 P13 N23
P13-
N23 P13 N23
P13-
N23 IAR %
B/L U/L
darmendran male 17 165 67 24.6 12.97 22.35 27.89 12.29 24.53 26.06 11.51 22.81 27.22 14.9 23.44 28.68 -0.03392 -3.39203 -0.02612 -2.61181
AASHISH male 17 163 81 30.5 11.25 19.48 38.2 11.56 21.98 32.32 15.37 22.45 45.55 10.9 17.45 38.04 -0.08338 -8.33806 0.089843 8.984328
bhanu female 18 170 69 23.9 10.73 20.21 36.66 11.36 16 32.19 12.92 23.54 36.18 11.4 22.92 32.75 -0.06492 -6.49237 0.049761 4.976063
rajalakshmi female 20 167 65 23.3 16.98 22.4 19.77 14.43 22.5 21.2 13.6 18.28 19.57 14.7 21.15 23.3 0.034904 3.490359 -0.08701 -8.70072
madina begum female 21 165 70 25.7 11.98 19.85 29.4 11.41 22.87 23.84 0.73 23.75 16.93 12.5 20.31 25.17 -0.10443 -10.4433 -0.19572 -19.5724
karthikeyan male 22 162 85 32.4 12.61 24.17 18.38 15 18.8 26.06 12.5 23.44 24.02 12 24.38 25.19 0.172817 17.28173 -0.02378 -2.37757
kawtham male 23 174 84 27.7 12.08 23.02 20 15.58 22.5 19.67 11.56 20.42 27.7 13.7 21.56 23.07 -0.00832 -0.83186 0.091196 9.119559
SUKANYA female 24 155 69 28.7 10.42 25.1 28.88 13.86 21.25 26.89 13.66 19.89 28.45 13.3 22.66 27.13 -0.03568 -3.56823 0.02375 2.374955
parameshwary female 25 169 63 22.1 11.98 23.65 26.13 12.19 23.6 32.89 10.79 20.42 33.33 12.3 24.22 33.48 0.114537 11.45374 -0.00225 -0.22452
tamilarasi female 26 170 72 24.9 13.18 23.7 31.12 10.42 21.69 30.16 15.63 23.23 28.5 13.2 18.44 28.53 -0.01567 -1.56658 -0.00053 -0.0526
susheela female 30 168 52 18.4 9.48 20.4 22.15 10.83 21.78 18.53 10.83 21.78 18.16 10.9 18.54 24.22 -0.08899 -8.89872 -0.14299 -14.2992
ramesh male 31 161 70 27 12.19 21.3 26.27 12.19 22.08 30.62 12.19 21.67 30.93 14.2 21.67 24.69 0.076463 7.646335 0.11219 11.21899
meena female 32 160 63 24.6 11.41 17.71 23.89 10.42 21.57 17.65 10.42 21.77 18.14 11.5 24.38 19.08 -0.15022 -15.0217 -0.02526 -2.52552
Thiyagarajan male 35 172 82 27.7 10.63 17.4 21.62 11.98 20.42 17.17 10.68 15.47 11.93 10.7 24.27 17.39 -0.11472 -11.472 -0.18622 -18.6221
kalyanasundaram male 36 157 42 17 10.73 24.69 26.35 11.84 23.04 23.52 13.23 21.46 20.13 11.8 23.85 16.13 -0.05675 -5.67475 0.110314 11.03144
hemalatha female 37 170 76 26.3 11.15 23.3 22.78 10.78 27.97 25.68 10.83 27.5 24.04 10.9 24.9 25.42 0.059843 5.984317 -0.0279 -2.79013
amsa female 39 155 65 27.1 10.63 18.44 27.4 13.54 19.58 27.6 11.36 22.92 24.23 10.4 26.25 27.11 0.003636 0.363636 -0.0561 -5.60966
lakshminarayanan male 40 167 78 28 10.89 17.5 24.64 10.63 18.13 23.44 10.83 17.97 25.52 10.6 0.08 24.27 -0.02496 -2.49584 0.025105 2.510544
rajam female 41 161 67 25.8 10.73 23.02 25.57 11.25 18.44 23.79 11.25 18.44 25.25 10.9 18.44 22.03 -0.03606 -3.60616 0.068105 6.810491
poongavanam female 42 165 70 25.7 11.15 22.19 14.65 12.66 21.88 18.46 12.5 21.98 18.21 10.4 24.27 19.22 0.115071 11.5071 -0.02698 -2.69837
selvi female 45 155 53 22.1 11.15 24.33 11.13 10.42 21.98 14.25 12.5 21.98 10.98 10.8 24.27 15.48 0.122931 12.29314 -0.17007 -17.0068
latheefa female 46 164 80 29.7 13.39 21.98 19.59 11.56 21.42 23.86 10.73 25 28.63 13 22.97 25.34 0.098274 9.827388 0.06096 6.095979
murugan male 47 165 60 22 13.13 20.1 32.36 10.94 20 38.88 11.98 24.12 32.54 11.3 25.47 32.8 0.091522 9.152162 -0.00398 -0.39792
mary m female 48 168 71 25.2 12.35 21.67 12.46 10.42 22.71 13.15 10.42 23.13 16.83 11.7 22.35 13.62 0.026943 2.69426 0.105419 10.54187
amudha female 50 171 73 25 10.42 22.5 18.57 12.19 26.5 16.57 12.19 22.61 18.66 10.4 22.5 15.84 -0.05692 -5.69152 0.081739 8.173913
mahalakshmi N female 52 170 74 25.6 10.42 27.55 15.16 10.42 27.08 15.88 12.71 22.12 14.51 11.7 24.17 15.81 0.023196 2.319588 -0.04288 -4.2876
suganthi female 53 168 65 23 11.88 22.71 16.93 10.99 22.45 11.49 10.99 22.4 12 11.9 23.33 12.78 -0.19141 -19.1414 -0.03148 -3.1477
tamilselvi female 55 170 62 29.5 17.09 23.08 6.81 12.3 21.34 8.29 14.1 24.27 6.94 10.1 23.06 6.3 0.098013 9.801325 0.048338 4.833837
PRAKASH M male 61 160 70 27.3 12.11 20.63 12.49 12.23 18.75 15.34 12.24 18.75 17.27 12.5 20.64 14.49 0.102407 10.24075 0.087531 8.753149
KALADEVI female 63 166 65 23.6 12.67 18.88 17.78 12.04 19.17 18.27 12.71 19.17 18.03 12.9 18.87 17.87 0.013592 1.359223 0.004457 0.445682
MIGRAINE WITHOUT VERTIGO B/L LEFT B/L RIGHT U/L RT HR U/L LT HR
name gender AGE
HEI
GHT
WEIG
HT BMI P13 N23
P13-
N23 P13 N23
P13-
N23 P13 N23
P13-
N23 P13 N23
P13-
N23 IAR %
B/L U/L
indhu female 17 166 68 24.7 11.36 17.4 27.45 10.42 20.29 28.72 13.13 21.57 28.05 10.42 26.25 22.42 0.02261 2.260993 0.111551 11.15514
shabeena female 18 160 55 21.5 12.5 18.27 36.76 10.42 22.26 24.85 11.98 20.42 27.17 11.57 22.97 26.4 -0.19331 -19.3313 0.014374 1.437372
vigneshwari female 21 170 74 25.6 11.77 21 37.65 11.04 21.35 48 13.91 21.6 39.6 10.58 21.58 32.37 0.120841 12.08406 0.100459 10.04585
gayathri female 25 162 70 26.7 11.04 22.19 20.93 14.27 21.45 29.03 10.89 21.77 33.1 11.56 21.58 26.83 0.16213 16.21297 0.104622 10.46221
latha n female 26 175 90 29.4 11.56 18.54 25.17 10.73 17.4 25.06 10.83 17.45 19.52 10.73 18.44 19.54 -0.00219 -0.21899 -0.00051 -0.0512
mohamedkadarnushamale 27 168 70 24.8 10.83 20.57 27.29 11.57 23.33 28.75 13.65 20.42 26.08 11.98 22.92 21.6 0.026053 2.605282 0.09396 9.395973
rajalakshmi female 29 162 68 25.9 13.23 16.67 25.89 14.79 20.24 30.23 11.64 21.6 28.76 12.71 23.23 26.37 0.077334 7.733428 0.043352 4.335208
selvi female 29 165 70 25.7 11.63 23.03 27.58 10.42 23.75 23.75 12.56 21.35 17.17 11.67 24.59 24.54 -0.07462 -7.46152 -0.1767 -17.6696
radha female 30 173 69 23.1 13.96 24.9 37.17 13.23 21.2 15.06 10.63 23.62 22.63 11.15 24.69 21.11 -0.42332 -42.332 0.034751 3.47508
sngeetha female 32 161 63 24.3 12.27 22.6 26.93 10.52 22.68 27.23 10.73 16.1 32.92 13.17 22.6 35.59 0.005539 0.553914 -0.03897 -3.89724
mutharasan male 33 167 73 26.2 11.46 17.24 27.87 11.04 21.04 30.48 10.83 22.19 28.01 10.94 18.44 26.73 0.04473 4.473008 0.023383 2.338327
malliga female 37 170 65 22.5 10.42 22.6 8.74 12.19 22.4 9.32 12.19 22.4 10.08 10.42 22.5 8.75 0.032115 3.211517 0.070632 7.063197
uma female 37 165 55 20.2 12.17 24.8 25.46 15.31 22.82 25.9 11.88 21.25 22.51 13.28 25.06 21.11 0.008567 0.856698 0.032095 3.209537
mahalakshmi female 40 174 70 23.1 11.22 22.19 19.58 12.19 23.2 20.81 12.48 20.33 19.78 12.42 15.21 23.93 0.030453 3.045308 -0.09494 -9.49439
mary female 42 160 65 25.4 12.6 23.33 13.66 12.92 23.33 18.78 13.54 21.88 24.7 10.63 26.04 20.81 0.15783 15.78298 0.085476 8.547572
s shanthi female 46 168 66 23.4 10.94 17.14 30.37 10.73 22.35 23.13 10.73 16.41 24.43 10.94 18.44 21.38 -0.13533 -13.5327 0.066579 6.657935
kumari male 47 163 66 24.8 10.52 22.5 21.1 11.2 21.93 21.73 12.19 21.98 16.89 12.42 22.5 23.33 0.014709 1.470932 -0.16012 -16.0119
neelaveni female 50 174 71 23.5 11.06 21.77 17.29 10.63 23.54 25.66 11.51 22.82 29.18 11.72 22.08 21.7 0.194878 19.48778 0.147013 14.70126
chandra female 52 166 71 25.8 10.94 19.58 11.27 10.83 19.6 10.74 10.83 19.6 10.73 10.94 19.74 11.35 -0.02408 -2.408 -0.02808 -2.80797
sangeetha .P female 55 175 80 26.1 13.08 20.13 18.81 12.04 20.1 13.42 12.63 23.03 11.66 14.59 20.11 10.23 -0.16724 -16.7235 0.065327 6.532663
80 CONTROL GROUP B/L LEFT B/L RIGHT U/L RT HR U/L LT HR
gender AGE
HEIGH
T
WEIG
HT P13 N23 P13-N23 P13 N23
P13-
N23 P13 N23
P13-
N23 P13 N23
P13-
N23 P13 N23 P13-N23 B/L U/L
NANDINI female 17 170 54 11.04 18.44 52.54 16.36 21.57 46.78 9.74 19.95 60.49 9.69 16.35 59.69 11.7075 19.0775 54.875 -0.05799 -5.79944 0.006657 0.665668
SANGEETHA female 17 160 60 10.63 21.92 40.93 10.63 21.44 39.03 10.42 22.14 56.25 11.04 21.78 54.28 10.68 21.82 47.6225 -0.02376 -2.37619 0.017823 1.782322
HARIHARAN male 17 170 47 10.42 18.44 52.14 10.47 16.62 59.01 10.42 17.4 50.23 10.42 18.44 51.31 10.4325 17.725 53.1725 0.061808 6.180837 -0.01064 -1.06362
ABDUL RAJAK male 17 174 61 11.72 24.27 56 10.42 18.44 58.23 10.63 18.44 57.25 10.63 14.54 56.98 10.85 18.9225 57.115 0.019522 1.952202 0.002364 0.236365
ABHSHEK male 17 165 55 10.42 26.04 28.73 10.53 25.97 34.24 11.98 25.57 29.78 11.36 25.75 36.33 11.0725 25.8325 32.27 0.087502 8.750199 -0.09908 -9.90773
VAISHNAVI female 18 172 50 10.42 17.87 49.78 14.17 21.83 45.8 12.97 20.83 47.09 10.73 18.44 48.93 12.0725 19.7425 47.9 -0.04164 -4.16405 -0.01916 -1.91627
RAJESH male 18 171 55 16.94 19.17 36.19 13.13 21.72 41.29 13.44 22.29 39.16 12.45 23.39 36.83 13.99 21.6425 38.3675 0.065823 6.582344 0.030662 3.066193
SATHYASAGAR male 18 168 60 13.23 21.98 41.15 11.7 18.75 42.18 12.5 18.54 42.1 12.5 21.53 42.23 12.4825 20.2 41.915 0.01236 1.236049 -0.00154 -0.15416
VISHNU female 19 168 50 11.67 26.46 35.01 11.25 21.56 35.68 13.33 20.94 35.38 15.63 25.26 34.62 12.97 23.555 35.1725 0.009478 0.9478 0.010857 1.085714
VINODHINI female 19 168 50 12.08 22.81 39.55 10.42 18.44 41.9 10.42 23.23 35.3 10.52 24.7 39.4 10.86 22.295 39.0375 0.028852 2.885206 -0.05489 -5.48862
VIJISHA female 20 168 64 10.42 27.55 37.6 11.46 24.06 32.77 13.7 26.04 39.79 13.85 26.31 35.22 12.3575 25.99 36.345 -0.06864 -6.86372 0.060925 6.092521
SASHIKUMAR male 20 168 67 10.52 25.21 45.16 11.2 24.17 43.16 10.42 24.17 48.1 10.42 25.83 46.95 10.64 24.845 45.8425 -0.02264 -2.26449 0.012099 1.20989
JAYACHANDRAN male 21 170 65 12.5 18.44 47.79 12.67 20 53.66 10.94 19.48 42.48 10.73 19.38 43.94 11.71 19.325 46.9675 0.057861 5.786102 -0.01689 -1.68942
MEENAKUMARI female 21 158 60 12.71 26.04 40.8 12.71 22.04 42.8 15.63 22.5 38.38 13.44 20.42 35.78 13.6225 22.75 39.44 0.023923 2.392344 0.035059 3.505933
BENETTA female 22 160 60 17.5 21.88 38.7 12.82 25.83 42.83 10.83 23.64 39.18 10.53 21.67 41.62 12.92 23.255 40.5825 0.050656 5.06562 -0.0302 -3.0198
JAYASIMMAN male 22 147 87 13.54 27.08 34.43 10.42 27.5 39.11 11.04 26.57 38.55 11.04 26.67 37.04 11.51 26.955 37.2825 0.063639 6.363884 0.019976 1.997619
KRISHNA male 23 173 68 10.34 19.79 47.43 10.54 18.36 48.18 10.73 19.12 35.08 10.63 18.75 37.12 10.56 19.005 41.9525 0.007844 0.784437 -0.02825 -2.82548
SEERANGAMMAL female 23 154 45 12.97 20.27 56.95 10.42 24.06 47.7 10.42 23.98 46.56 10.68 25.01 44.32 11.1225 23.33 48.8825 -0.08839 -8.83899 0.024648 2.464789
KASI RAJAN male 24 160 60 13.85 19.17 55.67 12.19 18.44 59.6 11.26 18.83 45.01 11.67 19.56 42.19 12.2425 19 50.6175 0.034094 3.409387 0.032339 3.233945
POOVIZHI female 24 165 55 10.73 14.64 50.64 10.53 24.48 42.8 14.12 24.38 48.7 12.14 24.58 45.73 11.88 22.02 46.9675 -0.0839 -8.39041 0.031452 3.145187
VANITHA female 25 153 54 10.47 27.45 48 14.38 24.63 42.05 12.67 18.99 48 11.52 24.21 45.98 12.26 23.82 46.0075 -0.06607 -6.60744 0.021494 2.149393
LATHA female 25 168 61 11.7 22.5 38.98 11.56 21.98 36.92 11.45 22.04 38.6 11.05 21.01 36.56 11.44 21.8825 37.765 -0.02714 -2.7141 0.027142 2.71421
PREETI female 26 157 65 11.96 22.4 42.65 11.77 18.44 48.03 11.77 18.44 47.29 13.96 22.29 45.47 12.365 20.3925 45.86 0.05933 5.932951 0.019621 1.962053
RAJI female 26 163 62 11.17 22.6 56.1 10.42 23.55 57.88 10.42 23.44 55.65 13.96 22.29 54.47 11.4925 22.97 56.025 0.015617 1.561677 0.010716 1.071558
KISHORE male 27 158 66 11.08 18.44 48.66 10.83 18.44 48.09 10.83 18.44 49.68 12.08 18.55 49.34 11.205 18.4675 48.9425 -0.00589 -0.58915 0.003434 0.343365
KAUTHAM male 28 154 65 11.19 18.44 67.44 10.83 25.63 54.08 10.83 25.63 51.34 12.29 18.44 45.44 11.285 22.035 54.575 -0.10994 -10.9941 0.060963 6.096301
FEBIN JOSEPH male 29 150 55 11.87 24.06 52.26 10.63 25.21 49.78 10.63 26.51 46.68 13.96 23.85 43.38 11.7725 24.9075 48.025 -0.0243 -2.43042 0.036642 3.664224
ANBU female 29 161 67 10.46 19.38 51.09 10.79 21.98 45.24 11.04 20.42 45.22 10.42 19.67 47.7 10.6775 20.3625 47.3125 -0.06073 -6.07287 -0.02669 -2.66896
CHANDRAKALA female 30 156 60 10.42 18.44 45.14 13.86 21.25 46.89 13.45 20.18 46.6 13.66 19.89 48.45 12.8475 19.94 46.77 0.019016 1.901554 -0.01946 -1.94634
USHA female 30 161 60 10.23 21.98 41.08 10.7 18.75 42.18 10.5 18.54 42.1 10.76 18.88 41.75 10.5475 19.5375 41.7775 0.013212 1.321163 0.004174 0.417412
RANDHEL SINGH male 31 159 65 11.67 23.46 38.06 11.25 21.56 25.68 13.33 20.94 38.08 13.28 23.45 41.72 12.3825 22.3525 35.885 -0.19423 -19.4227 -0.04561 -4.5614
ISHA SOOD female 32 149 60 11.01 21.81 42.33 12.92 17.14 44.8 12.5 16.88 43.6 12.67 18.44 44.23 12.275 18.5675 43.74 0.028348 2.834844 -0.00717 -0.71729
RATHI CHAWAN female 32 157 69 10.83 23.72 47.63 10.75 23.54 42.72 10.98 22.94 39.18 11.71 23.72 42.67 11.0675 23.48 43.05 -0.05434 -5.43442 -0.04264 -4.2639
SASHI male 33 158 72 12.81 18.75 43.12 11 21.77 47.43 13.7 21.77 49.4 12.81 22.08 45.28 12.58 21.0925 46.3075 0.047598 4.759801 0.043515 4.3515
VISHWANATH male 34 163 73 13.54 22.08 51.88 11.25 27.29 52.35 12.5 24.48 51.94 12.6 23.02 51.16 12.4725 24.2175 51.8325 0.004509 0.450926 0.007565 0.756547
SATHYANARAYANAN male 34 168 90 11.15 19.01 43.23 10.52 18.96 43.86 10.42 21.98 43.33 10.42 24.33 40.08 10.6275 21.07 42.625 0.007234 0.72339 0.038964 3.896415
ARUL PRASANNA male 35 173 75 11.67 21.26 33.48 10.52 20.42 26.29 11.67 21.72 39.97 11.67 21.88 39.76 11.3825 21.32 34.875 -0.12029 -12.0294 0.002634 0.263389
RAJARAMAN male 36 170 68 13.96 18.39 37.92 12.81 18.86 35.35 13.7 19.79 35.73 13.44 19.79 40.22 13.4775 19.2075 37.305 -0.03508 -3.50757 -0.05912 -5.91178
VASUDEVAN male 36 154 55 10.63 19.58 38.67 10.78 19.38 37.2 10.78 21.55 40.72 11.57 21.76 38.79 10.94 20.5675 38.845 -0.01938 -1.93752 0.024274 2.427368
GIRIJA female 37 162 62 10.42 18.44 42.98 10.83 26.15 41.52 12.6 20.52 43.2 10.63 23.44 43 11.12 22.1375 42.675 -0.01728 -1.72781 0.00232 0.232019
PRAKASH male 38 169 67 11.67 25.83 36.89 11.73 25.56 34.63 11.73 25.56 39.47 11.67 25.83 38.69 11.7 25.695 37.42 -0.0316 -3.15996 0.00998 0.997953
RAMESH KRISHNAN male 38 170 83 11.77 21.76 39.47 11.27 22.88 38.91 11.72 22.38 33.57 11.56 21.86 32.96 11.58 22.22 36.2275 -0.00714 -0.71447 0.009169 0.91688
KAVITHA female 39 152 72 11.35 19.27 45.95 14.17 21.67 45.24 12.5 20.42 48.28 11.35 20.42 46.6 12.3425 20.445 46.5175 -0.00779 -0.77859 0.017707 1.770658
ELUMALAI male 40 155 57 10.42 24.27 41.19 10.52 18.96 48.49 10.42 24.33 40.79 10.58 24.27 41.31 10.485 22.9575 42.945 0.081401 8.140054 -0.00633 -0.63337
RAVI P female 40 157 49 10.63 17.24 39.13 11.38 24.63 40.05 11.67 18.99 38 11.52 24.21 32.98 11.3 21.2675 37.54 0.011619 1.16191 0.070724 7.072415
PREETHA female 41 175 65 11.98 22.44 36.14 11.3 24.17 38.12 12.29 24.17 47.59 12.29 22.92 41.09 11.965 23.425 40.735 0.026663 2.666308 0.073297 7.329725
MOHAN male 41 151 62 12.5 23.33 38.89 13.02 23.13 38.95 12.08 21.67 38.09 12.5 23.33 38.99 12.525 22.865 38.73 0.000771 0.077081 -0.01168 -1.16762
S SARASWATHY female 42 154 49 12.31 22.2 42.27 12.5 21.35 41.52 11.48 22.87 44.8 11.52 25.32 38.53 11.9525 22.935 41.78 -0.00895 -0.89509 0.075243 7.524301
SASIKUMAR male 43 158 52 10.52 22.21 42.98 10.38 22.63 46.05 10.44 23.58 44.92 10.42 21.67 41.12 10.44 22.5225 43.7675 0.034483 3.448276 0.044166 4.41655
SIBI male 44 166 59 13.96 22.4 40.58 11.77 18.44 43.78 14.96 22.4 42.85 13.96 18.44 43.74 13.6625 20.42 42.7375 0.037933 3.793267 -0.01028 -1.02783
KARTHICK male 45 162 69 10.42 21.98 32.19 10.42 24.58 36.09 10.42 26.15 35.35 10.42 22.19 42.84 10.42 23.725 36.6175 0.057118 5.711775 -0.09579 -9.57923
AKALYA female 45 161 55 12.71 23.04 39.09 12.71 23.94 40.16 12.71 23.02 38.94 12.51 22.04 37.6 12.66 23.01 38.9475 0.013502 1.350158 0.017507 1.750719
AMBIGA female 46 177 65 12.6 19.27 44.29 10.13 19.27 49.88 10.23 22.01 52.59 12.78 19.7 46.56 11.435 20.0625 48.33 0.059361 5.936073 0.060817 6.081694
VARUN male 47 181 60 11.18 20.81 45.44 12.67 22.01 41.2 12.18 21.81 43.81 11.67 22.01 46.3 11.925 21.66 44.1875 -0.04894 -4.89381 -0.02763 -2.76329
BALAJI male 47 150 58 10.83 21.88 35.75 10.92 22.08 36.79 10.92 21.35 38.88 10.83 21.78 34.39 10.875 21.7725 36.4525 0.014337 1.433692 0.06128 6.12802
ANISHU female 48 152 54 10.55 18.75 47.89 10.48 18.86 37.97 10.54 18.96 38.49 10.44 18.85 38.66 10.5025 18.855 40.7525 -0.11554 -11.5537 -0.0022 -0.22035
ANITHA female 50 158 60 12.71 24.04 35.7 10.53 24.48 37.8 10.47 25.99 35.12 13.03 24.06 32.37 11.685 24.6425 35.2475 0.028571 2.857143 0.040747 4.074678
CHANDRU male 50 174 72 11.35 19.27 32.98 12.19 18.54 39.86 12.19 18.54 35.47 12.21 18.44 38.61 11.985 18.6975 36.73 0.094454 9.44536 -0.04239 -4.23866
DIVYA female 51 169 64 12.29 18.45 28.88 12.04 24.17 32.89 12.29 18.45 33.4 11.56 24.17 30.62 12.045 21.31 31.4475 0.064918 6.491825 0.043424 4.342393
KANCHANA female 52 153 55 12.63 21.98 33.59 11.52 22.04 35.31 11.04 21.98 35.87 12.18 22.04 32.49 11.8425 22.01 34.315 0.024964 2.496372 0.049444 4.944412
EESHWARI female 52 158 67 13.38 22.92 31.7 13.58 22.81 36.47 13.52 24.58 40.13 13.45 21.67 32.91 13.4825 22.995 35.3025 0.069972 6.997213 0.09885 9.884995
GOMATHY female 53 161 56 10.42 23.7 31.69 10.52 23.29 24.32 10.42 23.5 27.85 10.42 21.77 31.65 10.445 23.065 28.8775 -0.13158 -13.1584 -0.06387 -6.38655
GEETHUKISHAN female 54 163 50 10.63 18.75 27.54 10.63 18.75 26.7 10.83 19.06 25.08 10.73 18.75 30.04 10.705 18.8275 27.34 -0.01549 -1.54867 -0.08999 -8.99855
SUMAN male 55 170 66 12.5 20.08 32.43 12.43 21.44 29.74 12.02 19.88 39.01 12.5 19.98 38.89 12.3625 20.345 35.0175 -0.04327 -4.32685 0.00154 0.154044
ANJU female 55 159 51 11.04 21.67 26.57 11.04 22.65 34.19 11.04 21.65 28.24 11.04 21.76 28.88 11.04 21.9325 29.47 0.125411 12.54115 -0.0112 -1.12045
RAO male 57 183 70 12.81 22.6 22.18 11.56 21.98 26.92 11.45 22.04 29.6 11.45 21.01 28.56 11.8175 21.9075 26.815 0.096538 9.653768 0.017882 1.788171
BHARATH male 58 155 52 11.71 21.24 36.28 11.65 21.42 37.22 11.62 22.34 35.73 11.76 22.45 28.49 11.685 21.8625 34.43 0.012789 1.278912 0.112737 11.27375
SURESH BABU male 60 157 69 10.55 18.75 17.89 10.48 18.86 17.97 10.54 18.96 18.49 10.44 18.85 18.66 10.5025 18.855 18.2525 0.002231 0.22309 -0.00458 -0.4576
ZAHIR male 61 158 63 10.6 23.02 17.57 11.6 22.08 17.88 11.56 22.08 16.67 11.67 23.02 14.83 11.3575 22.55 16.7375 0.008745 0.874471 0.058413 5.84127
PRAKASH M male 61 160 65 12.11 20.63 22.49 12.23 18.75 25.34 12.24 18.75 27.27 12.48 20.64 24.49 12.265 19.6925 24.8975 0.059586 5.958603 0.053709 5.370943
MICHAEL male 61 171 57 12.11 21.07 18.05 11.56 21.07 17.59 11.55 21.07 20.69 12.12 21.44 16.47 11.835 21.1625 18.2 -0.01291 -1.29068 0.113563 11.3563
DINESH male 62 168 67 12.89 18.16 16.05 12.88 18.72 18.84 12.97 18.93 18.03 12.89 18.28 17.06 12.9075 18.5225 17.495 0.079966 7.996561 0.027643 2.76432
RAJAGOPAL male 63 152 54 10.67 19.27 18.32 10.56 21.67 25.71 11.66 21.56 23.56 11.57 21.4 18.43 11.115 20.975 21.505 0.16784 16.78401 0.122172 12.21719
SUMATHI female 63 149 60 10.52 20.21 17.98 10.52 23.33 17.05 11.54 22.56 17.92 11.52 22.5 21.73 11.025 22.15 18.67 -0.02655 -2.65487 -0.09609 -9.60908
RAJESH male 64 152 55 10.69 22.89 22.47 10.76 22.87 25.87 10.59 22.98 25.59 10.78 22.98 21.88 10.705 22.93 23.9525 0.070335 7.033513 0.078155 7.815462
RATHINAVEL male 65 153 78 13.07 18.44 17.2 13.32 18.56 18.82 13.17 18.56 19.43 13.13 18.44 16.93 13.1725 18.5 18.095 0.044975 4.497501 0.068757 6.875688
KUPPU female 66 162 61 10.52 21.88 18.12 10.52 21.78 16.53 10.55 21.66 16.05 10.54 21.77 18.93 10.5325 21.7725 17.4075 -0.04589 -4.58874 -0.08233 -8.23328
PADMASINI female 67 167 73 11.25 24.58 15.41 12.15 24.44 18.98 11.25 24.43 15.78 11.52 21.58 20.19 11.5425 23.7575 17.59 0.103809 10.38092 -0.1226 -12.2602
JULIA female 68 166 74 11.43 21.56 19.9 11.43 21.88 19.91 11.43 21.88 18.29 11.43 21.56 17.83 11.43 21.72 18.9825 0.000251 0.025119 0.012735 1.273533
HEMAMBUJAVALLI female 70 165 66 10.42 24.06 12.92 10.98 21.15 15.41 10.98 20.97 18.9 10.91 23.35 17.82 10.8225 22.3825 16.2625 0.087893 8.789269 0.029412 2.941176
20CONTROLS FOR REFERENCE STERNUM WRIST MASTOID
p13 latency B/L LT B/L RT U/L RT U/L LT B/L LT B/L RT U/L RT U/L LT B/L LT B/L RT U/L RT U/L LT
ARUL PRASSANNA 17 173 90 11.67 10.52 10.52 11.67 11.25 10.52 10.52 11.67 11.67 10.52 10.52 11.67
FEBIN JOSEPH 17 172 61 14.67 14.52 14.52 14.67 11.25 12.52 2.52 11.67 11.67 12.52 12.52 11.67
VIVEKANAND 17 171 55 11.67 10.52 10.52 11.67 11.25 10.52 10.52 11.67 11.67 10.52 10.52 11.67
SASHIREKA 18 168 61 12.81 10.99 13.7 12.81 12.81 10.75 13.75 12.81 12.81 10.75 13.75 12.81
VARSHINI 18 168 50 12.71 10.73 13.75 12.81 12.4 10.75 11.75 12.81 12.81 11.75 11.75 12.81
ANUP 18 168 64 12.81 11.25 13.65 12.81 12.81 11.75 11.75 12.81 12.81 11.65 11.62 12.81
VISHWAM 19 168 67 13.54 14.25 12.5 12.6 12.7 12.69 12.81 12.71 12.1 12.81 13.33 12.81
VANDANA OJHA 19 168 65 14.34 13.25 13.5 13.65 12.6 12.56 12.81 12.6 12.6 11.81 11.33 12.81
TARUN 19 170 60 13.54 11.25 12.5 12.6 12.8 12.81 12.81 12.81 12.81 11.61 11.33 12.81
RITESH 20 154 60 12.76 11.45 12.67 12.55 12.75 12.65 12.72 12.56 12.71 12.37 12.77 12.31
SOWMYA 20 160 87 11.93 11.78 11.92 11.78 12.28 12.01 11.98 11.78 11.01 11.56 11.67 11.56
SHANTHINI 21 159 68 12.41 11.69 11.73 12.41 11.72 11.08 11.18 11.72 11.62 11.08 11.18 11.62
PRATIMA 21 165 45 11.92 11.56 11.65 11.92 11.59 11.83 11.73 11.69 11.04 10.83 10.89 11.04
SELVI 22 153 60 13.85 15.63 15.43 12.08 11.56 13.23 12.4 13.23 12.45 11.84 13.85 11.56
SUGAPRIYA 23 168 70 12.22 12.42 12.89 13.32 10.42 11.08 11.9 10.62 11.61 10.43 10.56 11.67
GANDHIMATHI 23 174 55 13.01 13.75 13.45 13.44 11.25 11.15 12.97 12.79 11.67 11.56 11.72 12.04
VENKATASELVAM 24 165 54 13.24 13.75 13.33 13.54 13.67 11.23 11.76 11.03 13.45 13.28 13.02 13.19
DEVI 24 174 61 13.19 13.85 13.42 11.47 12.49 12.58 12.09 13.23 12.14 13.26 12.76 13.14
DHANAM 25 172 70 12.86 13.88 12.58 13.18 11.82 11.48 11.56 11.05 11.83 11.74 10.73 11.63
YALINI DEVI 25 171 55 12.59 12.61 12.98 13.06 11.44 11.57 11.67 11.54 11.82 11.81 10.73 11.64
KUMARAN DEV 26 168 64 14.42 14.79 14.06 14.16 11.33 11.69 12.48 11.89 12.83 12.63 12.67 12.98
SANTOSHVARAN 26 168 61 11.43 11.46 11.73 11.49 10.42 10.88 10.92 10.52 11.02 11.91 11.89 11.73
STERNUM WRIST MASTOID
n23 latency B/L LT B/L RT U/L RT U/L LT B/L LT B/L RT U/L RT U/L LT B/L LT B/L RT U/L RT U/L LT
ARUL PRASSANNA 17 173 90 21.26 20.42 18.44 21.88 24.17 18.54 18.44 24.17 22.82 18.44 18.44 24.54
FEBIN JOSEPH 17 172 61 20.63 20.42 18.44 21.88 24.17 18.54 18.44 24.17 21.46 18.44 18.44 24.9
VIVEKANAND 17 171 55 21.88 20.42 18.44 21.88 24.17 18.54 18.44 24.17 24.17 18.44 18.44 24.17
SASHIREKA 18 168 61 22.85 21.77 21.77 22.08 18.75 21.04 21.98 18.75 18.75 21.04 21.04 18.75
VARSHINI 18 168 50 22.75 21.77 21.77 22.08 18.75 21.04 21.98 18.75 18.75 21.04 21.04 18.75
ANUP 18 168 64 19.99 21.77 21.77 22.08 18.75 21.04 21.98 18.75 18.75 21.04 21.04 18.75
VISHWAM 19 168 67 22.08 27.29 27.19 23.02 20.73 21.77 21.77 18.75 23.02 27.19 27.19 23.02
VANDANA OJHA 19 168 65 22.08 27.29 21.77 23.02 18.44 21.77 21.77 18.75 23.02 27.19 21.77 23.02
TARUN 19 170 60 22.08 27.29 24.48 23.02 23.02 21.77 21.77 18.75 23.02 27.19 24.48 23.02
RITESH 20 154 60 23.12 23.43 23.08 23.12 22.67 22.66 22.72 22.81 22.98 22.67 22.96 22.78
SOWMYA 20 160 87 23.18 23.09 23.58 23.18 23.01 22.79 22.59 22.93 22.44 22.56 22.67 22.48
SHANTHINI 21 159 68 18.81 18.23 18.66 18.73 17.66 18.01 17.98 17.69 18.94 18.23 17.73 17.45
PRATIMA 21 165 45 19.83 19.97 19.63 19.55 19.03 8.17 19.17 20.61 19.73 19.07 18.99 18.98
SELVI 22 153 60 21.56 21.89 21.74 22.55 19.89 19.15 19.42 19.49 22.07 19.98 19.33 18.77
SUGAPRIYA 23 168 70 24.55 22.85 22.96 24.69 18.45 18.19 18.56 20.78 21.93 21.11 21.15 21.57
GANDHIMATHI 23 174 55 24.43 20.23 23.56 23.65 23.51 24.85 23.57 23.75 23.51 23.45 23.25 23.01
VENKATASELVAM 24 165 54 24.93 24.39 24.39 24.47 20.14 20.63 20.36 20.3 20.56 20.95 20.85 20.41
DEVI 24 174 61 24.08 23.32 23.23 24.11 22.53 22.25 23.15 22.74 22.69 22.96 23.48 23.84
DHANAM 25 172 70 20.94 20.81 20.93 21.33 20.33 20.47 20.73 20.84 21.63 21.89 21.47 21.03
YALINI DEVI 25 171 55 22.83 23.07 22.03 24.44 20.21 20.8 20.74 19.74 20.43 23.06 20.23 20.12
KUMARAN DEV 26 168 64 21.97 21.22 21.89 22.74 19.46 19.38 19.83 9.47 21.87 21.43 21.52 21.05
SANTOSHVARAN 26 168 61 24.67 24.06 23.76 24.76 22.56 22.22 23.22 21.56 23.66 23.87 24.03 22.88
STERNUM WRIST MASTOID
p13-n23 B/L LT B/L RT U/L RT U/L LT B/L LT B/L RT U/L RT U/L LT B/L LT B/L RT U/L RT U/L LT
ARUL PRASSANNA 17 173 90 53.48 56.29 52.72 58.26 46.72 46 44.35 45.54 54.81 52.83 51.59 47.79
FEBIN JOSEPH 17 172 61 64.49 66.74 62.91 68.79 60.68 61.15 61.96 61.53 60.51 63.36 61.06 67.95
VIVEKANAND 17 171 55 52.47 52.84 53.52 52.73 46.75 45.84 43.74 45.67 51.1 51.29 48.12 47.62
SASHIREKA 18 168 61 58.05 57.84 58.03 55.71 48.76 47.11 48.31 49.08 51.27 51.39 51.14 51.77
VARSHINI 18 168 50 61.77 61.47 61.27 65.85 58.68 57.23 48.19 59 58.26 58.43 60.18 59.92
ANUP 18 168 64 57.87 58.2 57.78 55.57 55.83 56.98 55.43 55.15 51.28 53.34 52.09 55.61
VISHWAM 19 168 67 52.12 52.62 50.25 51.58 44.18 44.7 45.3 49.62 46.45 49.43 46.34 46.14
VANDANA OJHA 19 168 65 61.88 61.35 57.94 60.86 60.17 54.23 55.29 55.71 56.53 59.09 57.59 56.19
TARUN 19 170 60 51.73 52.08 55.63 51.45 47.18 45.17 45.31 49.52 50.36 49.76 45.08 46.09
RITESH 20 154 60 55.33 51.33 51.73 55.78 50.34 51.73 51.93 50.39 51.76 50.73 53.01 52.12
SOWMYA 20 160 87 56.85 57.74 57.76 57.38 55.65 54.83 50.73 52.13 53.34 54.76 53.17 53.84
SHANTHINI 21 159 68 60.53 59.74 59.38 56.63 53.24 53.72 53.81 53.42 55.44 55.76 55.76 55.44
PRATIMA 21 165 45 57.93 58.48 57.83 56.13 51.87 52.42 52.14 52.87 53.17 53.77 53.78 53.09
SELVI 22 153 60 51.34 51.83 59.32 51.87 50.93 50.87 50.22 51.93 50.67 50.38 51.86 51.57
SUGAPRIYA 23 168 70 54.77 54.56 52.01 48.77 50.01 51.2 51.2 50.07 48.56 48.73 48.38 48.92
GANDHIMATHI 23 174 55 55.67 55.71 55.23 55.01 50.74 50.39 50.82 50.19 52.18 52.12 52.23 52.43
VENKATASELVAM 24 165 54 54.47 49.98 49.98 53.47 47.77 45.01 45.01 47.77 51.22 47.59 46.59 50.45
DEVI 24 174 61 49.63 49.63 48.55 48.92 45.39 45.84 46.72 45.76 47.2 47.23 47.82 47.83
DHANAM 25 172 70 49.65 49.88 49.27 49.65 44.02 44.2 44.12 44.56 45.65 45.34 45.92 48.03
YALINI DEVI 25 171 55 53 51.17 52.38 53.54 52.74 52.98 52.88 52.96 51.18 51.24 52.38 52.37
KUMARAN DEV 26 168 64 53.33 51.83 51.27 51.28 51.57 51.83 51.24 52.74 50.55 50.57 50.84 50.33
SANTOSHVARAN 26 168 61 52.38 52.34 53.86 53.94 50.43 48.43 49.72 50.83 49.92 49.83 50.08 50.34

